Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Mar. 31, 2022 | May 10, 2022 | Sep. 30, 2021 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Mar. 31, 2022 | ||
Current Fiscal Year End Date | --03-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-36766 | ||
Entity Registrant Name | New Relic, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 26-2017431 | ||
Entity Address, Address Line One | 188 Spear Street | ||
Entity Address, Address Line Two | Suite 1000 | ||
Entity Address, City or Town | San Francisco | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94105 | ||
City Area Code | 650 | ||
Local Phone Number | 777-7600 | ||
Title of 12(b) Security | Common Stock, par value $0.001 per share | ||
Trading Symbol | NEWR | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 4.1 | ||
Entity Common Stock, Shares Outstanding | 66,920,164 | ||
Documents Incorporated by Reference | Portions of the registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended March 31, 2022. | ||
Entity Central Index Key | 0001448056 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Mar. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Firm ID | 34 |
Auditor Name | DELOITTE & TOUCHE LLP |
Auditor Location | San Francisco, California |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 268,695 | $ 240,821 |
Short-term investments | 559,984 | 575,254 |
Accounts receivable, net of allowances of $3,073 and $2,633, respectively | 226,182 | 174,027 |
Prepaid expenses and other current assets | 29,447 | 21,944 |
Deferred contract acquisition costs | 24,058 | 36,210 |
Total current assets | 1,108,366 | 1,048,256 |
Property and equipment, net | 68,368 | 91,308 |
Restricted cash | 5,775 | 5,642 |
Goodwill | 163,677 | 144,253 |
Intangible assets, net | 15,636 | 12,986 |
Deferred contract acquisition costs, non-current | 10,463 | 32,579 |
Lease right-of-use assets | 50,465 | 57,425 |
Other assets, non-current | 4,916 | 6,170 |
Total assets | 1,427,666 | 1,398,619 |
Current liabilities: | ||
Accounts payable | 32,545 | 24,171 |
Accrued compensation and benefits | 37,023 | 37,196 |
Other current liabilities | 36,098 | 19,174 |
Deferred revenue | 398,754 | 373,594 |
Lease liabilities | 11,103 | 7,886 |
Total current liabilities | 515,523 | 462,021 |
Convertible senior notes, net | 497,663 | 449,380 |
Lease liabilities, non-current | 49,809 | 59,924 |
Deferred revenue, non-current | 108 | 1,674 |
Other liabilities, non-current | 20,173 | 8,256 |
Total liabilities | 1,083,276 | 981,255 |
Redeemable non-controlling interest | 21,686 | 3,389 |
Stockholders’ equity: | ||
Common stock, $0.001 par value; 100,000 shares authorized at March 31, 2022 and March 31, 2021; 66,988 shares and 64,019 shares issued at March 31, 2022 and March 31, 2021; and 66,728 shares and 63,759 shares outstanding at March 31, 2022 and March 31, 2021 | 66 | 64 |
Treasury stock—at cost (260 shares) | (263) | (263) |
Additional paid-in capital | 1,114,221 | 1,001,309 |
Accumulated other comprehensive loss | (8,012) | (19) |
Accumulated deficit | (783,308) | (587,116) |
Total stockholders’ equity | 322,704 | 413,975 |
Total liabilities, redeemable non-controlling interest and stockholders’ equity | $ 1,427,666 | $ 1,398,619 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 3,073 | $ 2,633 |
Common stock, par value (in usd per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 66,988,000 | 64,019,000 |
Common stock, shares outstanding (in shares) | 66,728,000 | 63,759,000 |
Treasury stock (in shares) | 260,000 | 260,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 785,521 | $ 667,648 | $ 599,510 |
Cost of revenue | 256,279 | 181,564 | 103,237 |
Gross profit | 529,242 | 486,084 | 496,273 |
Operating expenses: | |||
Research and development | 211,856 | 174,851 | 148,159 |
Sales and marketing | 394,027 | 361,702 | 334,319 |
General and administrative | 151,912 | 120,931 | 99,284 |
Total operating expenses | 757,795 | 657,484 | 581,762 |
Loss from operations | (228,553) | (171,400) | (85,489) |
Other income (expense): | |||
Interest income | 2,862 | 7,888 | 15,482 |
Interest expense | (4,921) | (24,901) | (23,695) |
Other income (expense), net | (1,170) | (1,918) | 2,934 |
Loss before income taxes | (231,782) | (190,331) | (90,768) |
Income tax provision | 323 | 559 | 211 |
Net loss | (232,105) | (190,890) | (90,979) |
Net loss and adjustment attributable to redeemable non-controlling interest | (18,297) | (1,720) | 2,042 |
Net loss attributable to New Relic | $ (250,402) | $ (192,610) | $ (88,937) |
Net loss attributable to New Relic per share, basic (in usd per share) | $ (3.88) | $ (3.15) | $ (1.52) |
Net loss attributable to New Relic per share, diluted (in usd per share) | $ (3.88) | $ (3.15) | $ (1.52) |
Weighted-average shares used to compute net loss per share, basic (in shares) | 64,592 | 61,070 | 58,601 |
Weighted-average shares used to compute net loss per share, diluted (in shares) | 64,592 | 61,070 | 58,601 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Net loss attributable to New Relic | $ (250,402) | $ (192,610) | $ (88,937) |
Other comprehensive loss: | |||
Unrealized gain (loss) on available-for-sale securities, net of tax | (7,993) | (4,888) | 4,224 |
Comprehensive loss attributable to New Relic | $ (258,395) | $ (197,498) | $ (84,713) |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Stock | Additional Paid-In Capital | Additional Paid-In CapitalCumulative Effect, Period of Adoption, Adjustment | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Accumulated DeficitCumulative Effect, Period of Adoption, Adjustment |
Beginning balance (in shares) at Mar. 31, 2019 | 58,366 | 260 | |||||||
Beginning balance at Mar. 31, 2019 | $ 349,630 | $ 58 | $ 654,759 | $ (263) | $ 645 | $ (305,569) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Issuance of common stock upon exercise of stock options (in shares) | 502 | ||||||||
Issuance of common stock upon exercise of stock options | 11,632 | $ 1 | 11,631 | ||||||
Issuance of common stock for vested restricted stock units (in shares) | 960 | ||||||||
Issuance of common stock for vested restricted stock units | 0 | $ 1 | (1) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 270 | ||||||||
Issuance of common stock related to employee stock purchase plan | 13,603 | 13,603 | |||||||
Stock-based compensation expense | 100,487 | 100,487 | |||||||
Other comprehensive income (loss), net | 4,224 | 4,224 | |||||||
Net loss attributable to New Relic | (88,937) | (88,937) | |||||||
Ending balance (in shares) at Mar. 31, 2020 | 60,098 | 260 | |||||||
Ending balance at Mar. 31, 2020 | $ 390,639 | $ 60 | 780,479 | $ (263) | 4,869 | (394,506) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2020-06 | ||||||||
Issuance of common stock upon exercise of stock options (in shares) | 462 | ||||||||
Issuance of common stock upon exercise of stock options | $ 6,865 | $ 0 | 6,865 | ||||||
Issuance of common stock for vested restricted stock units (in shares) | 1,536 | ||||||||
Issuance of common stock for vested restricted stock units | 0 | $ 2 | (2) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 302 | ||||||||
Issuance of common stock related to employee stock purchase plan | 14,425 | 14,425 | |||||||
Issuance of common stock related to acquisition of business (in shares) | 1,621 | ||||||||
Issuance of common stock related to acquisition of business | 62,367 | $ 2 | 62,365 | ||||||
Stock-based compensation expense | 137,177 | 137,177 | |||||||
Other comprehensive income (loss), net | (4,888) | (4,888) | |||||||
Net loss attributable to New Relic | (192,610) | (192,610) | |||||||
Ending balance (in shares) at Mar. 31, 2021 | 64,019 | 260 | |||||||
Ending balance at Mar. 31, 2021 | $ 413,975 | $ (45,926) | $ 64 | 1,001,309 | $ (100,136) | $ (263) | (19) | (587,116) | $ 54,210 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Issuance of common stock upon exercise of stock options (in shares) | 848 | 848 | |||||||
Issuance of common stock upon exercise of stock options | $ 31,868 | $ 1 | 31,867 | ||||||
Issuance of common stock for vested restricted stock units (in shares) | 1,505 | ||||||||
Issuance of common stock for vested restricted stock units | 0 | $ 1 | (1) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 214 | ||||||||
Issuance of common stock related to employee stock purchase plan | 12,272 | 12,272 | |||||||
Issuance of common stock related to acquisition of business (in shares) | 402 | ||||||||
Issuance of common stock related to acquisition of business | 13,487 | 13,487 | |||||||
Stock-based compensation expense | 155,423 | 155,423 | |||||||
Other comprehensive income (loss), net | (7,993) | (7,993) | |||||||
Net loss attributable to New Relic | (250,402) | (250,402) | |||||||
Ending balance (in shares) at Mar. 31, 2022 | 66,988 | 260 | |||||||
Ending balance at Mar. 31, 2022 | $ 322,704 | $ 66 | $ 1,114,221 | $ (263) | $ (8,012) | $ (783,308) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Cash flows from operating activities: | |||
Net loss attributable to New Relic | $ (250,402) | $ (192,610) | $ (88,937) |
Net loss and adjustment attributable to redeemable non-controlling interest (Note 3) | 18,297 | 1,720 | (2,042) |
Net loss: | (232,105) | (190,890) | (90,979) |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||
Depreciation and amortization | 86,065 | 89,312 | 75,743 |
Stock-based compensation expense | 153,039 | 135,143 | 99,536 |
Amortization of debt discount and issuance costs | 2,357 | 22,336 | 21,107 |
Gain on lease modification | 0 | 0 | (3,006) |
Other | 1,429 | 3,610 | (1,399) |
Changes in operating assets and liabilities, net of acquisition of businesses: | |||
Accounts receivable, net | (53,319) | (27,084) | (28,425) |
Prepaid expenses and other assets | (5,796) | (7,571) | 760 |
Deferred contract acquisition costs | (2,345) | (46,953) | (39,505) |
Lease right-of-use assets | 8,294 | 959 | 21,751 |
Accounts payable | 9,745 | 11,766 | 7,436 |
Accrued compensation and benefits and other liabilities | 19,564 | 18,778 | 5,044 |
Lease liabilities | (6,898) | 1,519 | (19,374) |
Deferred revenue | 23,594 | 58,941 | 44,730 |
Net cash provided by operating activities | 3,624 | 69,866 | 93,419 |
Cash flows from investing activities: | |||
Purchases of property and equipment | (5,778) | (18,737) | (58,218) |
Proceeds from sale of property and equipment | 1,001 | 0 | 0 |
Cash paid for acquisitions, net of cash acquired | (7,192) | (41,536) | (4,250) |
Purchases of short-term investments | (301,068) | (405,054) | (391,079) |
Proceeds from sale and maturity of short-term investments | 305,942 | 335,964 | 395,559 |
Capitalized software development costs | (12,662) | (13,494) | (6,641) |
Net cash used in investing activities | (19,757) | (142,857) | (64,629) |
Cash flows from financing activities: | |||
Investment from redeemable non-controlling interest | 0 | 0 | 978 |
Proceeds from employee stock purchase plan | 12,272 | 14,425 | 13,603 |
Proceeds from exercise of employee stock options | 31,868 | 6,865 | 11,632 |
Net cash provided by financing activities | 44,140 | 21,290 | 26,213 |
Net increase (decrease) in cash, cash equivalents and restricted cash | 28,007 | (51,701) | 55,003 |
Cash, cash equivalents and restricted cash at beginning of period | 246,463 | 298,164 | 243,161 |
Cash, cash equivalents and restricted cash at end of period | 274,470 | 246,463 | 298,164 |
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets: | |||
Cash and cash equivalents | 268,695 | 240,821 | 292,523 |
Restricted cash | 5,775 | 5,642 | 5,641 |
Total cash, cash equivalents and restricted cash | 274,470 | 246,463 | 298,164 |
Supplemental disclosure of cash flow information: | |||
Cash paid for interest and income taxes | 4,666 | 4,544 | 4,184 |
Noncash investing and financing activities: | |||
Issuance of common stock for the acquisition of business | 13,487 | 62,365 | 0 |
Property and equipment purchased but not paid yet | 8 | 1,776 | 2,196 |
Acquisition holdback | $ 7,250 | $ 0 | $ 850 |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 12 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | Description of Business and Summary of Significant Accounting Policies New Relic, Inc. (the “Company” or “New Relic”) was incorporated in Delaware on February 20, 2008, when it converted from a Delaware limited liability company called New Relic Software, LLC, which was formed in Delaware in September 2007. The Company delivers a software platform for customers to land all their telemetry data in one place and derive actionable insights from that data in a unified front-end application. The New Relic platform provides users with a consistent and comprehensive view of their digital environment allowing them to observe and operate all the components of their digital infrastructure. Basis of Presentation and Consolidation —The consolidated financial statements include the accounts of New Relic and its subsidiaries. These consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles, or GAAP. All intercompany balances and transactions have been eliminated in consolidation. Foreign Currency Translation and Transactions —The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. The Company translates all monetary assets and liabilities denominated in foreign currencies into U.S. dollars using the exchange rates in effect at the balance sheet dates and other assets and liabilities using historical exchange rates. Foreign currency-denominated revenue and expenses have been re-measured using the average exchange rates in effect during each period. Foreign currency re-measurement gains and losses have been included in other income (expense). Use of Estimates —The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Significant items subject to such estimates and assumptions include the fair value of share-based awards, fair value of purchased intangible assets and goodwill, variable consideration included in the transaction price for our customer contracts, useful lives of purchased intangible assets, unrecognized tax benefits, incremental borrowing rate used for operating lease liabilities, and the capitalization and estimated useful life of the Company’s software development costs. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from management’s estimates. COVID-19 —The COVID-19 pandemic has resulted in a global slowdown of economic activity that is expected to continue and which is likely to decrease demand for a broad variety of goods and services, while also disrupting sales channels and marketing activities for an unknown period of time. The Company’s revenue and deferred revenue have been negatively impacted by the slowdown in activity associated with the COVID-19 pandemic, but at this point, the extent of any continuing impact to the Company’s financial condition or results of operations is uncertain, particularly as the COVID-19 pandemic continues to persist for an extended period of time, and as of the date of issuance of these financial statements, management is not aware of any specific event or circumstance that would require an update to estimates and judgments or revising the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements. Segments —The Company’s chief operating decision maker is the Chief Executive Officer, who reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region. Accordingly, the Company has determined that it has a single reportable segment. Cash and Cash Equivalents —The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. Restricted Cash —The Company has an agreement to maintain cash balances at a financial institution as collateral for letters of credit relating to the Company’s property leases. Short-term Investments —Short-term investments consist of money market funds, certificates of deposit, commercial paper, U.S. treasury securities, U.S. agency securities, and corporate debt securities, and are classified as available-for-sale securities. The Company has classified its investments as current based on the nature of the investments and their availability for use in current operations. Available-for-sale securities are carried at fair value with unrealized gains and losses reported as a component of accumulated other comprehensive income, while realized gains and losses are reported within the statement of operations. The Company reviews its debt securities classified as short-term investments on a regular basis to evaluate whether or not any security has experienced an other-than-temporary decline in fair value. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial position and near-term prospects of the issuer, and the Company’s intent to sell, or whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s amortized-cost basis. If the Company determines that an other-than-temporary decline exists in one of these securities, the respective investment would be written down to fair value. For debt securities, the portion of the write-down related to credit loss would be recognized to other income, net in the consolidated statement of operations. Any portion not related to credit loss would be included in accumulated other comprehensive income (loss). The Company did not identify any investments as other-than-temporarily impaired as of March 31, 2022 or March 31, 2021. Business Combinations —The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. There has been no such adjustment as of March 31, 2022. Property and Equipment —Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for employee-related computers and software, three years for other office equipment and site-related computer hardware, and five years for furniture. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Down payments for property and equipment are recorded at cost and included in other assets in the accompanying consolidated balance sheet. Once the corresponding property and equipment item has been received, it will be reclassified to property and equipment and depreciated. Revenue Recognition —The Company generates revenue from subscription-based arrangements and usage-based arrangements that allow customers to access its products and/or platform. The Company determines revenue recognition through the following steps: • identification of the contract, or contracts with a customer; • identification of the performance obligations in the contract; • determination of the transaction price; • allocation of the transaction price to the performance obligations in the contract; and • recognition of revenue, when, or as, the Company satisfies a performance obligation. Revenue from subscription-based arrangements is recognized on a ratable basis over the contractual subscription period of the arrangement beginning when or as control of the promised goods or services is transferred to the customer. Beginning in the second quarter of fiscal 2021, the Company started offering usage-based pricing to its customers. Customers have the option to be charged upon their incurred usage in arrears (“Pay as You Go”), or they may commit to a minimum spend over their contracted period. Revenue related to Pay as You Go contracts are recognized based on the customers’ actual usage. Revenue related to commitment contracts are recognized on a ratable basis over the contract period including an estimate of usage above the minimum commitment. Usage above minimum commitment is estimated by looking at usage in previous months and other factors and projecting out for the rest of the contract. The estimated usage-based revenues are constrained to the amount the Company expects to be entitled to receive in exchange for providing access to its platform. Deferred Revenue —Deferred revenue consists of billings or payments received in advance of revenue being recognized. The Company generally invoices its customers monthly, quarterly, or annually. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue and the remaining portion is recorded as non-current deferred revenue. Cost of Revenue —Cost of revenue consists of expenses relating to data center operations, hosting-related costs, payment processing fees, depreciation and amortization, consulting costs, and salaries and benefits of operations and global customer support personnel. Accounts Receivable and Allowance for Doubtful Accounts —Accounts receivable are recorded at the invoiced amount, net of allowances for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine whether a specific allowance is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for doubtful accounts when identified. For all periods presented, the allowance for doubtful accounts activity was not significant. Software Development Costs —The Company capitalizes certain development costs incurred in connection with its internal use software and website. These capitalized costs are primarily related to its software tools that are hosted by the Company and accessed by its customers on a subscription basis. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases when the software is released or made available. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally three years. The Company capitalized $16.4 million, $17.6 million, and $8.1 million in internal use software during the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Included in the capitalized development costs were $3.7 million, $4.1 million, and $1.5 million of stock-based compensation costs for the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Amortization expense totaled $10.7 million, $7.0 million, and $4.9 million during the fiscal years ended March 31, 2022, 2021, and 2020, respectively. The net book value of capitalized internal use software as of March 31, 2022 and 2021, which is recorded in property and equipment on the accompanying consolidated balance sheets, was $28.0 million and $23.2 million, respectively. The Company also capitalizes qualifying implementation costs incurred in a hosting arrangement that is a service contract based on the existing guidance for internally developed software. In accordance with the guidance, (i) capitalized implementation costs are classified in the same balance sheet line item as the amounts prepaid for the related hosting arrangement; (ii) amortization of capitalized implementation costs are presented in the same income statement line item as the service fees for the related hosting arrangement; and (iii) cash flows related to capitalized implementation costs are presented within the same category of cash flow activity as the cash flows for the related hosting arrangement (i.e. operating activity). The Company tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The Company amortizes capitalized implementation costs over the expected life of the service contract. The Company capitalized $1.6 million, $2.1 million, and $2.5 million in implementation costs for software hosting arrangements during the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Amortization expense totaled $1.3 million, $1.2 million, and $0.2 million during the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Commissions —Previously the Company capitalized incremental commissions related to initial contracts and amortized such costs over the expected period of benefit, which the Company has determined to be three years, because the commissions paid upon renewal were not commensurate with the commissions paid on initial contracts. With our shift to a consumption model pricing strategy, a significant majority of commissions are no longer capitalized because commissions paid upon renewal are now commensurate and instead mostly expensed as incurred. Commissions expense is recorded in sales and marketing expense within the consolidated statement of operations. Advertising Expenses —Advertising is expensed as incurred and is included in sales and marketing in the consolidated statements of operations. Advertising expense was $29.0 million, $24.5 million, and $21.8 million for the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Operating Leases —The Company leases office space under non-cancelable operating leases which expire from 2022 to 2031. All of its office leases are classified as operating leases with lease expense recognized on a straight-line basis over the lease term. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company considers information including, but not limited to, the lease term, the Company's credit rating and interest rates of similar debt instruments with comparable credit ratings. The lease right-of-use assets are also increased by any lease prepayments made and reduced by any lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain that the Company will exercise the extension option. The Company’s operating leases typically include nonlease components such as common-area maintenance costs. The Company has elected to include nonlease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease payments. Leases with a term of one year or less are not recognized on the Company’s consolidated balance sheet. Impairment of Long-Lived Assets —Long-lived assets, such as property and equipment, acquired intangible assets, and capitalized software development costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by the asset to its carrying value. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. For the fiscal years presented, the Company had not impaired any of its long-lived assets. Goodwill —Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the third quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Since inception through March 31, 2022, the Company did not have any goodwill impairment. Intangible Assets —Intangible assets consist of identifiable intangible assets, primarily developed technology, resulting from the Company’s acquisitions. Acquired intangible assets are recorded at cost, net of accumulated amortization. Intangible assets are amortized on a straight-line basis over their estimated useful lives. Stock-Based Compensation —The Company estimates the fair value of share-based awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the statements of operations. The Company recognizes compensation expense for the majority of its awards over the vesting period of the entire award using the straight-line attribution method. These amounts are reduced by an estimated forfeiture rate. The forfeiture rate is estimated based on actual cancellation experience and is applied to all share-based awards. The rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company selected the Black-Scholes option-pricing model as the method for determining the estimated fair value for stock options and shares pursuant to the Company’s 2014 Employee Stock Purchase Plan, or ESPP. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, which determine the fair value of share-based awards, including the option’s expected term and the price volatility of the underlying stock. The Company uses a Monte Carlo simulation model to determine the fair value of its performance stock units, or PSUs, and recognizes expense using the accelerated attribution method over the requisite service period. The authoritative guidance prohibits the recognition of a deferred tax asset for an excess tax benefit that has not yet been included in the Company’s tax return. As a result, the Company will only recognize an excess tax benefit from stock-based compensation in the period in which it is included in the Company’s tax return. Fair Value Measurements —The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and accrued liabilities, due to their short-term nature. Concentration of Risk —Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, short-term investments, and trade accounts receivable. The Company invests its excess cash in money market funds, certificates of deposit, commercial paper, U.S. treasury securities, U.S. agency securities, and corporate debt securities with major financial institutions. Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, are subject to minimal credit risk. There were no customers that represented more than 10% of the Company’s accounts receivable balance as of March 31, 2022 and March 31, 2021. In addition, there were no customers that individually exceeded 10% of the Company’s revenue during the fiscal years ended March 31, 2022, 2021, and 2020. Income Taxes —The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. In addition, deferred tax assets are recorded for the future benefit of utilizing net operating losses and research and development credit carryforwards. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statement of operations. Net Loss Per Share —The Company’s basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period. For purposes of this calculation, options to purchase common stock, common stock reserved for issuance, restricted stock units, convertible debt, and shares issuable pursuant to the ESPP are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share as their effect is antidilutive. Recently Issued Accounting Pronouncements Not Yet Adopted In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses an issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This guidance is effective for the Company’s fiscal year beginning April 1, 2022. The Company is currently evaluating the impact of adopting this guidance. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations - Accounting for Contract Liabilities from Contracts with Customers (Topic 805), which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under ASC 606 as if the entity had originated the contracts. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of adopting this guidance. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The Company adopted ASU 2020-06 effective April 1, 2021, using the modified retrospective basis, which resulted in a $54.2 million decrease to the opening balance of accumulated deficit, a $100.1 million decrease to the opening balance of additional paid-in capital, and a $45.9 million increase to the opening balance of the Notes, net on the consolidated balance sheet. |
Business Combinations
Business Combinations | 12 Months Ended |
Mar. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations During the fiscal year ended March 31, 2022 , the Company completed one acquisition, which is described below. CodeStream Inc. On June 8, 2021, the Company acquired all of the equity interests in CodeStream Inc. (“CodeStream”), a company that provides an integrated developer collaboration platform. The aggregate purchase price of $28.6 million consisted of approximately $15.1 million in cash (of which t he Company held back approximately $7.3 million from the aggregate purchase price for 18 months after the transaction closing date), and 202,561 shares of the Company’s common stock with an aggregate fair value of approximately $13.5 million. The held back cash was accrued as a long-term liability and has been re-classed as a short-term liability as of March 31. 2022. The fair value of the consideration transferred was determined based on a $66.58 per share price of the Company’s common stock on the closing date of the acquisition. The total purchase price was allocated to the developed technology acquired with an estimated useful life o f three years, net assets assumed, and a deferred tax liability related to the developed technology. The excess purchase price was recorded as goodwill. The acquisition was accounted for as a business combination in accordance with ASC 805. The estimated fair value of developed technology acquired of $10.3 million was determined through the use of a third-party valuation firm using cost approach methodology. The business combination did not have a material impact on the condensed consolidated financial statements and therefore historical and proforma disclosures have not been presented. The acquisition also included a holdback arrangement with certain employees of CodeStream, totaling approximately 199,492 shares of the Company’s common stock, contingent upon their continued employment with the Company. The fair value of these awards, which are subject to the recipients’ continued service, was $13.3 million and was excluded from the aggregate purchase price. These awards will be recognized as stock-based compensation expense over the vesting period, which is 42 months. The following table presents the preliminary purchase price allocation related to the acquisition (in thousands): Cash consideration paid $ 15,140 Fair value of common shares issued 26,768 Total consideration 41,908 Post-business combination compensation expense (13,282) Total purchase price 28,626 Net assets assumed (113) Deferred tax liabilities 1,211 Developed technology acquired (10,300) Goodwill $ 19,424 Pixie Labs Inc. On December 22, 2020, the Company acquired all of the equity interests in Pixie Labs Inc. (“Pixie Labs”), a company that provides a next-generation machine intelligence observability solution for developers using Kubernetes. The aggregate purchase price of $107.9 million consisted of approximately $45.6 million in cash (of which $15.0 million is being held in escrow for 12 months after the transaction closing date) and 884,269 shares of Company common stock with an aggregate fair value of approximately $62.4 million. The fair value of the consideration transferred was determined based on a $70.53 per share price of the Company’s common stock. The total purchase price was allocated to the developed technology acquired with an estimated useful life o f three years , net assets assumed, and a deferred tax liability related to the developed technology. The excess purchase price was recorded as goodwill, as set forth below. Goodwill generated from the acquisition is attributable to expected synergies from future growth and is not deductible for tax purposes. The following table presents the purchase price allocation related to the acquisition (in thousands): Cash consideration paid $ 45,558 Fair value of common shares issued 114,310 Total consideration 159,868 Post-business combination compensation expense (51,943) Total purchase price 107,925 Net assets assumed (4,099) Deferred tax liabilities 115 Developed technology acquired (4,800) Goodwill $ 99,141 The acquisition has been accounted for as a business combination. The direct transaction costs of the acquisition have been accounted for separately from the business combination and expensed as incurred. Total direct transaction costs incurred by the Company were $0.9 million , which were included in general and administrative expenses in the Company’s consolidated statement of operations for the fiscal year ended March 31, 2021. The Company pa id $0.6 million in acquisition-related expenses incurred by Pixie Labs related to Pixie Labs’ advisors which were included as part of the purchase consideration. The business combination did not have a material impact on the consolidated financial statements and therefore historical and proforma disclosures have not been presented. The acquisition also included a holdback arrangement with certain employees of Pixie Labs, totaling approximately 736,469 shares of the Company’s common stock, contingent upon their continued employment with the Company. The fair value of these awards, which are subject to the recipients’ continued service, was $51.9 million and was excluded from the aggregate purchase price. These awards will be recognized as stock-based compensation expense over the vesting period, which ranges from 18 months to 37 months. IOPipe,Inc. On October 31, 2019, the Company acquired certain assets of IOpipe, Inc., a company that provides monitoring tools for serverless applications, for $5.1 million in cash. The Company held back approximately $0.9 million from the aggregate purchase price which has been accrued as a liability. Of the total purchase price, $1.5 million was allocated to acquired technology with an estimated useful life of three years with the excess $3.6 million of the purchase price over the fair value of the intangible assets acquired recorded as goodwill. The acquisition has been accounted for as a business combination under the acquisition method. Goodwill and other intangibles generated from the acquisition are attributable to expected synergies from future growth and potential future monetization opportunities, and are deductible for tax purposes. The business combination did not have a material impact on the consolidated financial statements and therefore historical and proforma disclosures have not been presented. |
Joint Venture
Joint Venture | 12 Months Ended |
Mar. 31, 2022 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Joint Venture | Joint Venture On July 13, 2018, the Company entered into an agreement with Japan Cloud Computing L.P. (“JCC”) and M30 LLC (collectively, the Investors) to engage in the investment, organization, management, and operation of New Relic K.K., a Japanese subsidiary of the Company that is focused on the sale of the Company’s products and services in Japan. On August 21, 2018, the investors initially contributed approximately $3.6 million (396,000,000 Japanese Yen) in exchange for 40% of the outstanding common stock of New Relic K.K. On August 21, 2019, the Company and Investors additionally contributed approximately $1.5 million (156,000,000 Japanese Yen) and approximately $1.0 million (104,000,000 Japanese Yen), respectively, to subscribe to additional shares. As of March 31, 2022, the Company owned approximately 60% of the outstanding common stock in New Relic K.K. All of the common stock held by the Investors may be callable by the Company or puttable by the Investors upon certain contingent events. Should the call or put option be exercised, the redemption value would be determined based on a prescribed formula derived from the discrete revenues of New Relic K.K. and the Company and may be settled, at the Company’s discretion, with Company stock or cash. As a result of the put right available to the redeemable non-controlling interest holders in the future, the redeemable non-controlling interest in New Relic K.K. is classified outside of permanent equity in the Company’s consolidated balance sheet as of March 31, 2022, and the balance is reported at the greater of the initial carrying amount adjusted for the redeemable non-controlling interest’s share of earnings or losses, or its estimated redemption value. Accordingly, the Company adjusted the redeemable non-controlling interest by $18.6 million at March 31, 2022. The following table summarizes the activity in the redeemable non-controlling interest for the period indicated below: March 31, 2022 March 31, 2021 March 31, 2020 Balance, beginning of period $ 3,389 $ 1,669 $ 2,733 Investment by redeemable non-controlling interest — — 978 Net loss attributable to redeemable non-controlling interest (282) (1,421) (2,042) Adjustment to redeemable non-controlling interest 18,579 3,141 — Balance, end of period $ 21,686 $ 3,389 $ 1,669 |
Revenue
Revenue | 12 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue The Company offers a comprehensive suite of products delivered on its open and extensible cloud-based platform that enable organizations to collect, store, and analyze massive amounts of data in real time so they can better operate their applications and infrastructure and improve their digital customer experience. The Company generates revenue from subscription-based arrangements and usage-based arrangements that allow customers to access its products and/or platform. Revenue from subscription-based arrangements is recognized on a ratable basis over the contractual subscription period of the arrangement beginning when or as control of the promised goods or services is transferred to the customer. Beginning in the second quarter of fiscal 2021, the Company started offering usage-based pricing to its customers. Customers have the option to be charged upon their incurred usage in arrears (“Pay as You Go”), or they may commit to a minimum spend over their contracted period. Revenue related to Pay as You Go contracts are recognized based on the customers’ actual usage. Revenue related to commitment contracts are recognized on a ratable basis over the contract period including an estimate of usage above the minimum commitment. Usage above minimum commitment is estimated by looking at usage in previous months and other factors and projecting out for the rest of the contract. The estimated usage-based revenues are constrained to the amount the Company expects to be entitled to receive in exchange for providing access to its platform. Deferred revenue consists of billings or payments received in advance of revenue being recognized. Disaggregation of Revenue For disaggregated revenue by geography, refer to Note 16—Revenue by Geographic Location. Contract Balances In a response to the COVID-19 pandemic, the Company performed additional procedures to evaluate the creditworthiness of its customers and assess collectability of accounts. Using a current expected credit loss model, the Company determined that, while there may be a delay in collections due to the downturn in economic activity, there has not been a material impact to the risk of credit loss on accounts receivables as of March 31, 2022. The Company receives payments from customers based upon billing cycles. As the Company performs under customer contracts, its right to consideration that is unconditional is considered to be accounts receivable. If the Company’s right to consideration for such performance is contingent upon a future event or satisfaction of additional performance obligations, the amount of revenues the Company has recognized in excess of the amount it has billed to the customer is considered to be a contract asset. Contract assets were $1.5 million and $2.5 million as of March 31, 2022 and March 31, 2021, respectively. The Company has no asset impairment charges related to contract assets for the periods presented. Deferred revenue represents consideration received from customers in excess of revenues recognized. The following table presents the changes to the Company’s deferred revenue (in thousands): March 31, 2022 March 31, 2021 Deferred revenue, beginning of period $ 375,268 $ 316,327 Contributions from contract asset (1,017) 2,446 Billings 810,132 724,143 Revenue recognized (785,521) (667,648) Deferred revenue, end of period $ 398,862 $ 375,268 For the fiscal years ended March 31, 2022 and 2021, approximately 47% of total revenue recognized was from the deferred revenue balances at the beginning of each period. For the fiscal year ended March 31, 2022, the Company recognized $9.8 million in revenue from performance obligations satisfied in prior periods. The amount recognized during the fiscal year ended March 31, 2021 from performance obligations satisfied in prior periods was immaterial. Contract Acquisition Costs The Company capitalizes certain contract acquisition costs primarily consisting of commissions. The balances of deferred costs to obtain customer contracts were $34.5 million and $68.8 million as of March 31, 2022 and March 31, 2021, respectively. In the fiscal years ended March 31, 2022 and 2021, amortization from amounts capitalized was $36.6 million and $38.3 million, respectively. In the fiscal years ended March 31, 2022 and 2021, amounts expensed as incurred were $62.7 million and $14.5 million, respectively. The Company had no impairment loss in relation to costs capitalized. Remaining Performance Obligations The Company’s contracts with customers generally include one main performance obligation, which is access to its SaaS-based products and platform. Within the main performance obligation, each service is generally considered a distinct stand-ready obligation that is recognized over the contract term based on the passage of time. As of March 31, 2022, the aggregate unrecognized transaction price of remaining performance obligations was $706.1 million. The Company expects to recognize more than 96% of the balance as revenue in the 24 months following March 31, 2022 and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized and does not include contract amounts which are cancellable by the customer and amounts associated with optional renewal periods. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company reports assets and liabilities recorded at fair value on the Company’s consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2—Inputs are quoted prices for similar assets and liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments. Level 3—Inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2022 and 2021 based on the three-tier fair value hierarchy (in thousands): Fair Value Measurements as of March 31, 2022 Level 1 Level 2 Level 3 Total Cash and cash equivalents: Money market funds $ 109,327 $ — $ — $ 109,327 Short-term investments: Certificates of deposit — 126,885 — 126,885 Commercial paper — 27,861 — 27,861 Corporate notes and bonds — 85,065 — 85,065 U.S. treasury securities 320,173 — — 320,173 Restricted cash: Money market funds 5,775 — — 5,775 Total $ 435,275 $ 239,811 $ — $ 675,086 Included in cash and cash equivalents $ 109,327 Included in short-term investments $ 559,984 Included in restricted cash $ 5,775 Fair Value Measurements as of March 31, 2021 Level 1 Level 2 Level 3 Total Cash and cash equivalents: Money market funds $ 101,626 $ — $ — $ 101,626 Short-term investments: Certificates of deposit — 48,099 — 48,099 Commercial paper — 11,681 — 11,681 Corporate notes and bonds — 39,873 — 39,873 U.S. treasury securities 475,601 — — 475,601 Restricted cash: Money market funds 5,642 — — 5,642 Total $ 582,869 $ 99,653 $ — $ 682,522 Included in cash and cash equivalents $ 101,626 Included in short-term investments $ 575,254 Included in restricted cash $ 5,642 There were no transfers between fair value measurement levels during the fiscal years ended March 31, 2022 and 2021. The Company invests in certificates of deposit, commercial paper, corporate debt securities, U.S. treasury securities, and U.S. agency securities, which are classified as available-for-sale securities. The following table presents our available-for-sale securities as of March 31, 2022 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Short-term investments: Certificates of deposit $ 127,500 $ — $ (615) $ 126,885 Commercial paper 27,946 — (85) 27,861 Corporate notes and bonds 87,259 — (2,194) 85,065 U.S. treasury securities 323,584 79 (3,490) 320,173 Total available-for-sale investments $ 566,289 $ 79 $ (6,384) $ 559,984 The following table presents the Company’s available-for-sale securities as of March 31, 2021 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Short-term investments: Certificates of deposit $ 48,100 $ 18 $ (19) $ 48,099 Commercial paper 11,676 5 — 11,681 Corporate notes and bonds 39,620 261 (8) 39,873 U.S. treasury securities 474,171 1,575 (145) 475,601 Total available-for-sale investments $ 573,567 $ 1,859 $ (172) $ 575,254 The Company did not consider any available-for-sale securities to be impaired as of March 31, 2022 or 2021 since a large percentage of the portfolio that was in an unrealized loss position for more than 12 months was invested in US Treasury securities, which have no credit risk . The following table classifies the Company’s available-for-sale short-term investments by contractual maturities as of March 31, 2022 and 2021 (in thousands): March 31, 2022 March 31, 2021 Due within one year $ 354,774 $ 299,032 Due after one year and within three years 205,210 276,222 Total $ 559,984 $ 575,254 For certain other financial instruments, including accounts receivable, accounts payable, and other current liabilities, the carrying amounts approximate their fair value due to the relatively short maturity of these balances. Convertible Senior Notes As of March 31, 2022, the fair value of the Company’s 0.50% convertible senior notes due 2023 (the “Notes”) was $455.0 million. The fair value was determined based on the quoted price of the Notes in an inactive market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. |
Property and Equipment
Property and Equipment | 12 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and Equipment Property and equipment, net, consisted of the following (in thousands): March 31, 2022 March 31, 2021 Computers, software, and equipment $ 13,854 $ 14,270 Site operation equipment 67,726 87,479 Furniture and fixtures 5,772 5,758 Leasehold improvements 49,756 49,751 Capitalized software development costs 79,808 66,451 Total property and equipment 216,916 223,709 Less: accumulated depreciation and amortization (148,548) (132,401) Total property and equipment, net $ 68,368 $ 91,308 Depreciation and amortization expense related to property and equipment during the fiscal years ended March 31, 2022, 2021, and 2020 was $40.5 million, $44.3 million, and $41.1 million, respectively. |
0.5% Convertible Senior Notes a
0.5% Convertible Senior Notes and Capped Call | 12 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
0.5% Convertible Senior Notes and Capped Call | 0.5% Convertible Senior Notes and Capped Call In May 2018, the Company issued $500.25 million in aggregate principal amount of Notes in a private offering, including $65.25 million in aggregate principal amount of Notes pursuant to the exercise in full of the initial purchasers’ option to purchase additional Notes. The Notes are the Company’s senior unsecured obligations and bear interest at a fixed rate of 0.5% per annum, payable semi-annually in arrears on May 1 and November 1 of each year, commencing on November 1, 2018. The Notes will mature on May 1, 2023, unless earlier converted or repurchased. Each $1,000 principal amount of the Notes will initially be convertible into 9.0244 shares of the Company’s common stock (the “Conversion Option”), which is equivalent to an initial conversion price of approximately $110.81 per share. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the indenture governing the Notes. In addition, following certain corporate events that occur prior to the maturity date, the Company will increase the conversion rate, in certain circumstances, for a holder who elects to convert its Notes in connection with such a corporate event. During the three and twelve months ended March 31, 2022, the conditions allowing holders of the Notes to convert have not been met. The Notes were therefore not convertible during the twelve months ended March 31, 2022 and were classified as long-term debt for such period. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding November 1, 2022, only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ending on September 30, 2018 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price (as defined in the indenture governing the Notes) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the Notes on each such trading day; or (3) upon the occurrence of specified corporate events as set forth in the indenture governing the Notes. On or after November 1, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the indenture governing the Notes. In accounting for the transaction, the Notes were separated into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The carrying amount of the equity component representing the Conversion Option was $102.5 million and was determined by deducting the fair value of the liability component from the proceeds received upon issuance of the Notes. The equity component was recorded in additional paid-in capital and is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the Notes over the liability component (the “Debt Discount”) and the debt issuance costs were amortized to interest expense over the contractual term of the Notes at an effective interest rate of 5.74%. This rate is inclusive of the issuance costs. In accounting for the debt issuance costs of $11.6 million related to the Notes, the Company allocated the total amount incurred to the liability and equity components using the same proportions as the proceeds of the Notes. Issuance costs attributable to the liability component were $9.2 million and were amortized to interest expense using the effective interest method over the contractual term of the Notes. Issuance costs attributable to the equity component were $2.4 million and netted with the equity component in additional paid-in capital. In the first quarter of fiscal 2022, the Company adopted ASU No. 2020-06, Accounting for Convertible Instruments and Contract on an Entity’s Own Equity . As a result of the adoption, the Conversion Option of $102.5 million and issuance costs of $2.4 million previously attributable to the equity component are no longer be presented in equity. Similarly, the debt discount, which was equal to the carrying value of the embedded conversion feature upon issuance, is no longer amortized into income as interest expense over the life of the instrument. As a result, the Company recorded a $54.2 million decrease to the opening balance of accumulated deficit, a $100.1 million decrease to the opening balance of additional paid-in capital, and a $45.9 million increase to the opening balance of the Notes, net on the consolidated balance sheet. The net carrying amount of the liability component of the Notes as of March 31, 2022 and 2021 was as follows (in thousands): March 31, 2022 March 31, 2021 Principal $ 500,250 $ 500,250 Unamortized debt discount — (46,378) Unamortized issuance costs (2,587) (4,492) Net carrying amount $ 497,663 $ 449,380 Interest expense related to the Notes is as follows (in thousands): March 31, 2022 March 31, 2021 Amortization of debt discount $ — $ 20,516 Amortization of issuance costs 2,357 1,820 Contractual interest expense 2,496 2,501 Total interest expense $ 4,853 $ 24,837 In connection with the offering of the Notes, the Company entered into privately negotiated capped call transactions with certain financial institutions (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $110.81 per share, subject to certain adjustments, which correspond to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $173.82 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, approximately 4.5 million shares of our common stock. Conditions that cause adjustments to the initial strike price of the Capped Calls mirror conditions that result in corresponding adjustments for the Notes. The Capped Calls are generally intended to reduce potential dilution to holders of the Company’s common stock upon any conversion of the Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset, as the case may be, subject to a cap based on the cap price. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The cost of $63.2 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital. The net impact related to stockholders’ equity has been included in additional paid-in capital and was a result of the issuance costs of $2.4 million and the purchase of capped calls noted above in the amount of $63.2 million. |
Goodwill and Purchased Intangib
Goodwill and Purchased Intangibles Assets | 12 Months Ended |
Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Purchased Intangibles Assets | Goodwill and Purchased Intangibles Assets The changes in the carrying amount of goodwill for the twelve months ended March 31, 2022 consisted of the following (in thousands): Goodwill as of March 31, 2021 $ 144,253 Goodwill acquired 19,424 Goodwill as of March 31, 2022 $ 163,677 Purchased intangible assets subject to amortization as of March 31, 2022 consisted of the following (in thousands): Gross Carrying Accumulated Net Carrying Developed technology $ 27,500 $ (11,864) $ 15,636 Purchased intangible assets subject to amortization as of March 31, 2021 consisted of the following (in thousands): Gross Carrying Accumulated Net Carrying Developed technology $ 20,116 $ (7,130) $ 12,986 Amortization expense of purchased intangible assets for the fiscal years ended March 31, 2022, 2021, and 2020 was $7.6 million, $5.5 million, and $1.7 million, respectively, and is included in cost of revenue on the Company’s consolidated statements of operations. Estimated future amortization expense as of March 31, 2022 is as follows (in thousands): Fiscal Years Ending March 31, Estimated Future Amortization Expense 2023 $ 9,000 2024 4,633 2025 2,003 $ 15,636 |
Other Current Liabilities
Other Current Liabilities | 12 Months Ended |
Mar. 31, 2022 | |
Other Liabilities Disclosure [Abstract] | |
Other Current Liabilities | Other Current Liabilities Other current liabilities consisted of the following (in thousands): As of March 31, 2022 2021 Accrued liabilities $ 4,145 $ 4,050 Accrued tax liabilities 1,196 1,042 Other 30,757 14,082 Total other current liabilities $ 36,098 $ 19,174 |
Leases
Leases | 12 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases The following table presents information about leases on the consolidated balance sheet (in thousands): March 31, 2022 March 31, 2021 Assets Lease right-of-use-assets $ 50,465 $ 57,425 Liabilities Lease liabilities $ 11,103 $ 7,886 Lease liabilities, non-current 49,809 59,924 Total operating lease liabilities $ 60,912 $ 67,810 As of March 31, 2022, the weighted average remaining lease term was 5.3 years and the weighted average discount rate was 6.8%. The following table presents information about leases on its consolidated statement of operations (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Operating lease expense $ 13,579 $ 13,870 $ 14,220 Short-term lease expense 832 843 1,074 Variable lease expense 2,872 2,581 2,682 The following table presents supplemental cash flow information about the Company’s leases (in thousands): Fiscal Year Ended March 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities $ 13,949 $ 15,666 Operating lease assets obtained in exchange for new lease liabilities (1) 2,611 8,525 (1) Includes the impact of new leases as well as remeasurements and modifications to existing leases. As of March 31, 2022, remaining maturities of lease liabilities were as follows (in thousands): Fiscal Years Ending March 31, Operating Leases 2023 $ 14,750 2024 14,118 2025 11,592 2026 11,795 2027 12,380 Thereafter 8,336 Total operating lease payments $ 72,971 Less imputed interest (12,059) Total operating lease liabilities $ 60,912 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Commitments —As of March 31, 2022 and 2021, the Company had purchase commitments of $549.4 million and $494.6 million, respectively, primarily related to data center, cloud and hosting services. In September 2020, the Company entered into an agreement with a public cloud hosting provider, under which it now has a total five-year minimum commitment of $500.0 million, which has been included in the commitment balance as of March 31, 2022 above. Other Contingencies —In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, |
Common Stock and Stockholders'
Common Stock and Stockholders' Equity | 12 Months Ended |
Mar. 31, 2022 | |
Equity [Abstract] | |
Common Stock and Stockholders' Equity | Common Stock and Stockholders’ Equity Common stock reserved for issuance —The Company had reserved shares of common stock for future issuance pursuant to equity plans as follows (in thousands): As of March 31, 2022 2021 Common stock options outstanding 1,663 2,718 RSUs outstanding 3,351 3,293 PSUs outstanding 320 112 Available for future stock option, RSU, and PSU grants 13,904 12,281 Available for future employee stock purchase plan awards 2,988 2,702 22,226 21,106 Employee Stock Purchase Plan —The Company’s board of directors adopted, and the Company’s stockholders approved, the Company’s 2014 Employee Stock Purchase Plan (the “ESPP”), which became effective in December 2014. The ESPP initially reserved and authorized the issuance of up to 1,000,000 shares of common stock. The ESPP provides that the number of shares reserved and available for issuance under the ESPP automatically increases each April, beginning on April 1, 2015, by the lesser of 500,000 shares, 1% of the number of the Company’s common stock shares issued and outstanding on the immediately preceding March 31, or such lesser number of shares as determined by the Company’s board of directors. For the fiscal years ended March 31, 2022, 2021, and 2020, 0.2 million shares, 0.3 million shares, and 0.3 million shares of common stock were purchased under the ESPP, respectively, and a total of $4.2 million, $5.5 million, and $5.3 million of stock-based compensation expense was recorded, respectively. As of March 31, 2022, 2,987,542 shares of common stock were available for issuance under the ESPP. 2008 Equity Incentive Plan —The Company’s board of directors adopted, and the Company’s stockholders approved, the 2008 Equity Incentive Plan, or the 2008 Plan, in February 2008. The 2008 Plan was terminated in connection with the Company’s initial public offering (“IPO”), and accordingly, no shares are available for future issuance under this plan. The 2008 Plan continues to govern outstanding awards granted thereunder. 2014 Equity Incentive Plan —The Company’s board of directors adopted, and the Company’s stockholders approved, the Company’s 2014 Equity Incentive Plan (the “2014 Plan”), which became effective in December 2014. The 2014 Plan serves as the successor to the Company’s 2008 Plan. The 2014 Plan initially reserved and authorized the issuance of 5,000,000 shares of the Company’s common stock. Additionally, shares not issued or subject to outstanding grants under the 2008 Plan upon its termination became available under the 2014 Plan, resulting in a total of 5,184,878 available shares under the 2014 Plan as of the effective date of the 2014 Plan. Pursuant to the terms of the 2014 Plan, any shares subject to outstanding stock options or other stock awards under the 2008 Plan that (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited because of the failure to meet a contingency or condition required to vest such shares or otherwise return to the Company or (iii) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection with an award or to satisfy the purchase price or exercise price of a stock award will become available for issuance pursuant to awards granted under the 2014 Plan. The 2014 Plan provides that the number of shares reserved and available for issuance under the plan automatically increases each April 1, beginning on April 1, 2015, by 5% of the outstanding number of shares of the Company’s common stock shares issued and outstanding on the immediately preceding March 31, or such lesser number of shares as determined by the Company’s board of directors. As of March 31, 2022, there were 13,904,194 shares available for issuance under the 2014 Plan. The following table summarizes the Company’s stock option, restricted stock unit (“RSU”), and performance unit (“PSU”) award activities for the fiscal year ended March 31, 2022 (in thousands, except exercise price, contractual term and fair value information): Options Outstanding RSUs Outstanding PSUs Outstanding Number of Shares Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value Number of Weighted- Weighted- Aggregate Number of Weighted- Weighted- Aggregate Outstanding—April 1, 2021 2,718 $ 50.55 6.2 $ 48,064 3,293 $ 67.76 2.8 $ 202,459 112 $ 99.05 2.0 $ 6,884 Granted (1) — — 2,710 69.94 241 82.89 Exercised/vested (848) 37.56 39,003 (1,472) 67.32 (33) 99.05 Canceled/forfeited (207) 70.77 (1,180) 66.83 — Outstanding - March 31, 2022 1,663 $ 54.66 5.6 $ 31,436 3,351 $ 70.04 2.6 $ 224,096 320 $ 86.88 1.8 $ 21,430 Options vested and expected to vest - March 31, 2022 1,662 $ 54.65 5.6 $ 31,436 Options vested and exercisable - March 31, 2022 1,310 $ 50.66 5.0 $ 30,233 RSUs and PSUs expected to vest - March 31, 2022 3,173 $ 69.54 $ 212,235 305 $ 87.00 $ 20,370 (1) The above table includes 241,398 performance unit awards and does not include any time-based restricted stock issued as consideration for an acquisition which are further detailed in the table below. PSUs granted under the 2014 Plan are contingent upon the achievement of pre-determined market and service conditions. The number of shares of common stock to be issued at vesting will range from 0% to 200% of the target number based on the Company’s total shareholder return (“TSR”) relative to the performance of peer companies for each measurement period, over a one-year, two-year cumulative, and three-year cumulative period. If these market conditions are not met but service conditions are met, the PSUs will not vest; however, any stock-based compensation expense recognized to date will not be reversed. The Company uses a Monte Carlo simulation model to determine the fair value of its PSUs and recognizes expense using the accelerated attribution method over the requisite service period. The PSUs presented in the table above were calculated based on 100% expected achievement. In April 2022, subsequent to the year-end, 129,991 PSUs had vested. The weighted-average grant-date fair value of options granted during the fiscal years ended March 31, 2022, 2021, and 2020 was $0.00, $26.51, and $30.67, respectively. Intrinsic value of options exercised during the fiscal years ended March 31, 2022, 2021, and 2020 was $39.0 million, $20.6 million, and $23.8 million, respectively. The total fair value of RSUs vested during the fiscal years ended March 31, 2022, 2021, and 2020 was $99.3 million, $107.1 million, and $63.3 million, respectively. Aggregate intrinsic value for options, RSUs, and PSUs outstanding represents the difference between the closing stock price of the Company’s common stock and the exercise price of outstanding, in-the-money awards. The Company’s closing stock price as reported on the New York Stock Exchange as of March 31, 2022, the last trading day of fiscal 2022, was $66.88. The following table summarizes the time-based restricted stock issued as consideration for an acquisition during the fiscal years ended March 31, 2022, 2021, and 2020: Fiscal Years Ending March 31, Number of Shares of Time-Based Restricted Stock Granted as Consideration for Acquisitions 2020 — 2021 736,469 (1) 2022 199,492 (2) (1) These shares were issued in connection with the Pixie Labs acquisition, which included a holdback arrangement with certain employees of Pixie Labs. These shares are subject to the recipients’ continued service and will be recognized as stock-based compensation expense over the vesting periods, which range from 18 months to 37 months from the closing date of the acquisition. (2) These shares were issued in connection with the CodeStream acquisition, which included a holdback arrangement with certain employees of CodeStream. These shares are subject to the recipients’ continued service and will be recognized as stock-based compensation expense over the vesting periods, which range from 18 months to 42 months from the closing date of the acquisition. Employee Stock Options and ESPP Valuation —The Company estimates the fair value of stock options and ESPP shares on the date of grant using the Black-Scholes option-pricing model. Each of the Black-Scholes inputs is subjective and generally requires significant judgments to determine. The assumptions used to estimate the fair value of stock options granted and ESPP shares to be issued during the fiscal years ended March 31, 2022, 2021, and 2020 were as follows: Stock Options: Fiscal Year Ended March 31, 2022 2021 2020 Expected term (years) 0 6 6 Expected volatility 0 - 0% 44 - 46% 41 - 42% Risk-free interest rate 0.00 - 0.00% 0.34 - 0.76% 1.45 - 3.06% Dividend yield — — — ESPP: Fiscal Year Ended March 31, 2022 2021 2020 Expected term (years) 0.5 0.5 0.5 Expected volatility 38 - 76% 55 - 76% 33 - 60% Risk-free interest rate 0.05 - 0.72% 0.06 - 0.12% 1.56 - 1.86% Dividend yield — — — Risk-Free Interest Rate The Company bases the risk-free interest rate used in the Black-Scholes option-pricing model on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. Expected Term The Company determines the expected term based on the average period the stock options are expected to remain outstanding generally calculated as the midpoint of the stock options vesting term and contractual expiration period. The Company estimates the expected term for ESPP shares using the purchase period of 6 months. Expected Volatility Beginning in April 2020, the expected volatility for options granted is based on the historical volatility of the Company’s common stock. The expected volatility for options granted prior to April 2020 was based on the historical volatilities of our publicly traded peer group. The Company uses historical volatility data when valuing ESPP shares. Dividend Yield The expected dividend assumption is based on the Company’s current expectations about its anticipated dividend policy. Stock-Based Compensation Expense —Aggregate stock-based compensation expense for employees and nonemployees was $153.0 million, $135.1 million, and $99.5 million for the fiscal years ended March 31, 2022, 2021, and 2020, respectively. Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Cost of revenue $ 5,042 $ 5,939 $ 5,303 Research and development 48,355 40,964 31,703 Sales and marketing 48,986 54,695 43,548 General and administrative (1) 50,656 33,545 18,982 Total stock-based compensation expense (2) $ 153,039 $ 135,143 $ 99,536 (1) Includes $9.6 million acceleration of share-based payment expense for the fiscal year ended March 31, 2022, for one of the Company’s executives due to his departure at the end of June 2021. (2) Includes $0.5 million expense for the fiscal year ended March 31, 2022, due to the restructuring activities commenced in the first quarter of fiscal 2022. Refer to Note 18. Restructuring for more information. As of March 31, 2022, unrecognized stock-based compensation cost related to outstanding unvested stock options was $9.8 million, which is expected to be recognized over a weighted-average period of approximately 1.8 years. As of March 31, 2022, unrecognized stock-based compensation cost related to outstanding unvested stock units was $251.7 million, which is expected to be recognized over a weighted-average period of approximately 2.5 years. As of March 31, 2022, unrecognized stock-based compensation cost related to PSUs was $10.0 million, which is expected to be recognized over a weighted-average period of approximately 1.8 years. |
Income Taxes
Income Taxes | 12 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The components of income (loss) before income taxes were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Domestic $ (238,068) $ (193,262) $ (93,687) Foreign 6,286 2,931 2,919 Total $ (231,782) $ (190,331) $ (90,768) The components of the provision for income taxes were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Current Provision: Federal $ — $ — $ (1,177) State 276 (9) 34 Foreign 1,385 685 1,632 Total current provision 1,661 676 489 Deferred Provision: Federal (1,120) 35 — State (64) (96) — Foreign (154) (56) (278) Total deferred provision (1,338) (117) (278) Total income tax provision $ 323 $ 559 $ 211 The items accounting for the difference between income taxes computed at the federal statutory rate and the provision for income taxes consisted of the following: Fiscal Year Ended March 31, 2022 2021 2020 Federal statutory rate 21.0 % 21.0 % 21.0 % Effect of: State taxes, net of federal benefits 3.5 3.0 3.0 Stock-based compensation 3.8 (1.5) (0.4) Research and development credits, net of ASC 740-10 2.5 2.4 5.1 Permanent items (4.4) (2.4) (4.0) Foreign taxes — 0.2 0.4 Intraperiod allocation — — 1.5 Other 0.5 0.7 0.7 Valuation allowance (27.0) (23.7) (27.5) Effective tax rate (0.1) % (0.3) % (0.2) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents the significant components of the Company’s deferred tax assets and liabilities for the periods presented (in thousands): As of March 31, 2022 2021 Deferred tax assets: Accrued expenses $ 2,568 $ 3,429 Depreciation and amortization 5,657 3,518 Capitalized research and development 24,050 — Net operating loss and other attribute carryforwards 196,159 178,535 Stock based compensation 20,695 14,987 Research and development credits 31,695 25,932 Lease liability 13,349 15,208 Convertible debt 3,638 — Other 4,530 378 Gross deferred tax assets 302,341 241,987 Valuation allowance (276,475) (198,794) Total deferred tax assets 25,866 43,193 Deferred tax liabilities: Prepaids (4,268) (3,949) Intangibles (2,679) (1,923) Capitalized research and development — (4,405) Deferred contract acquisition costs (7,326) (15,520) Convertible debt — (3,991) Right of use asset (10,809) (12,748) Total deferred tax liabilities (25,082) (42,536) Total net deferred tax assets/(liabilities) $ 784 $ 657 The Company accounts for deferred taxes under ASC 740, Income Taxes , which requires a reduction of the carrying amounts of deferred tax assets by a valuation allowance if, based on available evidence, it is more likely than not that such assets will not be realized. Accordingly, the need to establish valuation allowances for deferred tax assets is assessed periodically based on the ASC 740 more-likely-than-not realization threshold. This assessment considers matters such as future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies and results of recent operations. The evaluation of the recoverability of the deferred tax assets requires that we weigh all positive and negative evidence to reach a conclusion that it is more likely than not that all or some portion of the deferred tax assets will not be realized. The weight given to the evidence is commensurate with the extent to which it can be objectively verified. Based upon the weight of available evidence, which includes the Company’s historical operating performance and the U.S. and Japan cumulative net losses in all prior periods, the Company has provided a valuation allowance against its U.S. and Japan deferred tax assets. Overall, the valuation allowance increased by $77.7 million and $47.5 million for the years ended March 31, 2022 and 2021, respectively. As of March 31, 2022, the Company has U.S. federal and state net operating losses of approximately $776.7 million and $449.3 million, respectively, which expire beginning in the years 2028 and 2020. Of the $776.7 million federal net operating losses, $355.2 million are carried forward indefinitely but are limited to 80% of taxable income. The remaining $421.5 million begin to expire in 2028. As of March 31, 2022, the Company also has Federal, California and Oregon research and development credits of $37.4 million, $6.1 million, and $1.0 million, respectively. The federal tax credit carryforwards will expire beginning in 2028 if not utilized. The California credit carryforwards do not expire. The Oregon tax credit carryforwards began to expire in 2020. Utilization of the net operating loss carryforwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Code, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. Section 382 of the Code (“Section 382”) ownership change generally occurs if one or more stockholders or groups of stockholders who own at least 5% of the Company’s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. The Company did experience one or more ownership changes in financial periods ending on or before March 31, 2022. In this regard, the Company has determined that based on the timing of the ownership changes and the corresponding Section 382 limitations, none of its net operating losses or other tax attributes are subject to such limitation. The Company has adopted authoritative guidance which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company’s income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company had unrecognized tax benefits of $15.0 million, $12.2 million, and $10.3 million as of March 31, 2022, 2021, and 2020. As of March 31, 2022, if recognized, the unrecognized tax benefit of $14.8 million would not affect income tax expense before consideration of any valuation allowance. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months. Balance at March 31, 2019 $ 7,997 Additions based on tax positions taken during the current period 2,183 Additions based on tax positions taken during the prior period 687 Reductions based on tax positions taken during the prior period (529) Balance at March 31, 2020 10,338 Additions based on tax positions taken during the current period 2,667 Additions based on tax positions taken during the prior period 703 Reductions based on tax positions taken during the prior period (1,549) Balance at March 31, 2021 12,159 Additions based on tax positions taken during the current period 2,920 Additions based on tax positions taken during the prior period 430 Reductions based on tax positions taken during the prior period (521) Balance at March 31, 2022 $ 14,988 The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statement of operations. Accrued interest and penalties have not been material for the fiscal years ended March 31, 2022, 2021, and 2020 . |
Net Loss Per Share
Net Loss Per Share | 12 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | Net Loss Per ShareAs the Company had net losses for the fiscal years ended March 31, 2022, 2021, and 2020, all potential common shares were determined to be anti-dilutive. Additionally, the 4.5 million shares underlying the Conversion Option in the Notes are not considered in the calculation of diluted net loss per share as the effect would be anti-dilutive. The Notes were not convertible as of March 31, 2022. ASU 2020-06 eliminates the treasury stock method and instead requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share when the instruments may be settled in cash or shares. The required use of the if-converted method did not impact the diluted net loss per share as the Company was in a net loss position. The following table sets forth the computation of net loss per share, basic and diluted (in thousands, except per share amounts): Fiscal Year Ended March 31, 2022 2021 2020 Numerator: Net loss attributable to New Relic $ (250,402) $ (192,610) $ (88,937) Denominator: Weighted average shares used to compute net loss per share, basic and diluted 64,592 61,070 58,601 Net loss attributable to New Relic per share—basic and diluted $ (3.88) $ (3.15) $ (1.52) The following outstanding options, unvested shares, and ESPP shares were excluded (as common stock equivalents) from the computation of diluted net loss per common share for the periods presented as their effect would have been antidilutive (in thousands): As of March 31, 2022 2021 2020 Options to purchase common stock 1,663 2,718 2,850 RSUs 3,351 3,293 3,100 PSUs 320 112 — ESPP shares 45 48 69 5,379 6,171 6,019 |
Employee Benefit Plan
Employee Benefit Plan | 12 Months Ended |
Mar. 31, 2022 | |
Postemployment Benefits [Abstract] | |
Employee Benefit Plan | Employee Benefit PlanThe Company has established a 401(k) tax-deferred savings plan (the “401(k) Plan”), which permits participants to make contributions by salary deduction pursuant to Section 401(k) of the Code. The Company is responsible for administrative costs of the 401(k) Plan and may, at its discretion, make matching contributions to the 401(k) Plan. For the fiscal years ended March 31, 2022, 2021, and 2020, the Company made contributions of $8.5 million, $8.3 million, and $7.7 million to the 401(k) Plan, respectively. |
Revenue by Geographic Location
Revenue by Geographic Location | 12 Months Ended |
Mar. 31, 2022 | |
Segment Reporting [Abstract] | |
Revenue by Geographic Location | Revenue by Geographic Location The following table shows the Company’s revenue by geographic areas, as determined based on the billing address of its customers (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 United States $ 528,922 $ 460,944 $ 417,827 EMEA 121,301 104,184 98,651 APAC 79,940 62,590 50,831 Other 55,358 39,930 32,201 Total revenue $ 785,521 $ 667,648 $ 599,510 Substantially all of the Company’s long-lived assets were attributable to operations in the United States as of March 31, 2022 and 2021. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party TransactionsCertain members of the Company’s board of directors serve on the board of directors of and/or are executive officers of, and, in some cases, are investors in, companies that are customers or vendors of the Company. Revenue from sales to these companies of an aggregate of $3.1 million, $1.7 million, and $1.0 million was recognized for the fiscal years ended March 31, 2022, 2021, and 2020, respectively. There was not a significant amount of accounts receivable due from these companies as of March 31, 2022 or March 31, 2021. There were no expenses related to purchases from these companies during the fiscal years ended March 31, 2022 and 2021 and an aggregate of $1.4 million in expenses related to purchases during the fiscal year ended 2020. There was not a significant amount of accounts payable to these companies for the fiscal years ended March 31, 2022 and 2021. |
Restructuring
Restructuring | 12 Months Ended |
Mar. 31, 2022 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | Restructuring In the first quarter of fiscal 2022, the Company commenced a restructuring plan to realign its cost structure to better reflect significant product and business model innovation over the past 12 months. As a result of the restructuring plan, the Company incurred charges of approximately $12.6 million for employee terminations and other costs associated with the restructuring plan. Most of these charges consisted of cash expenditures and stock-based compensation expense which were recognized and mostly paid off in the first quarter of fiscal 2022. For the fourth quarter of fiscal 2022, the Company had an immaterial credit adjustment and had no restructuring charges for the same period last year. The Company incurred $12.6 million and $0 million in restructuring charges for the fiscal years ended March 31, 2022 and 2021, respectively. The following table shows the Company’s restructuring charges for the fiscal year ended March 31, 2022 (in thousands): Fiscal Year Ended March 31, 2022 Severance and other employee costs Stock-based compensation Asset impairment Total Sales and marketing $ 10,819 $ 406 $ 104 $ 11,329 General and administrative 1,170 87 26 1,283 Total $ 11,989 $ 493 $ 130 $ 12,612 |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business | Description of Business and Summary of Significant Accounting PoliciesNew Relic, Inc. (the “Company” or “New Relic”) was incorporated in Delaware on February 20, 2008, when it converted from a Delaware limited liability company called New Relic Software, LLC, which was formed in Delaware in September 2007. The Company delivers a software platform for customers to land all their telemetry data in one place and derive actionable insights from that data in a unified front-end application. The New Relic platform provides users with a consistent and comprehensive view of their digital environment allowing them to observe and operate all the components of their digital infrastructure. |
Basis of Presentation | Basis of Presentation and Consolidation—The consolidated financial statements include the accounts of New Relic and its subsidiaries. These consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles, or GAAP. |
Consolidation | All intercompany balances and transactions have been eliminated in consolidation. |
Foreign Currency Translation and Transactions | Foreign Currency Translation and Transactions —The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. The Company translates all monetary assets and liabilities denominated in foreign currencies into U.S. dollars using the exchange rates in effect at the balance sheet dates and other assets and liabilities using historical exchange rates. Foreign currency-denominated revenue and expenses have been re-measured using the average exchange rates in effect during each period. Foreign currency re-measurement gains and losses have been included in other income (expense). |
Use of Estimates | Use of Estimates —The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Significant items subject to such estimates and assumptions include the fair value of share-based awards, fair value of purchased intangible assets and goodwill, variable consideration included in the transaction price for our customer contracts, useful lives of purchased intangible assets, unrecognized tax benefits, incremental borrowing rate used for operating lease liabilities, and the capitalization and estimated useful life of the Company’s software development costs. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from management’s estimates. |
COVID-19 | COVID-19 —The COVID-19 pandemic has resulted in a global slowdown of economic activity that is expected to continue and which is likely to decrease demand for a broad variety of goods and services, while also disrupting sales channels and marketing activities for an unknown period of time. The Company’s revenue and deferred revenue have been negatively impacted by the slowdown in activity associated with the COVID-19 pandemic, but at this point, the extent of any continuing impact to the Company’s financial condition or results of operations is uncertain, particularly as the COVID-19 pandemic continues to persist for an extended period of time, and as of the date of issuance of these financial statements, management is not aware of any specific event or circumstance that would require an update to estimates and judgments or revising the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements. |
Segments | Segments —The Company’s chief operating decision maker is the Chief Executive Officer, who reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region. Accordingly, the Company has determined that it has a single reportable segment. |
Cash and Cash Equivalents | Cash and Cash Equivalents —The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. |
Restricted Cash | Restricted Cash —The Company has an agreement to maintain cash balances at a financial institution as collateral for letters of credit relating to the Company’s property leases. |
Short-term Investments | Short-term Investments —Short-term investments consist of money market funds, certificates of deposit, commercial paper, U.S. treasury securities, U.S. agency securities, and corporate debt securities, and are classified as available-for-sale securities. The Company has classified its investments as current based on the nature of the investments and their availability for use in current operations. Available-for-sale securities are carried at fair value with unrealized gains and losses reported as a |
Business Combinations | Business Combinations—The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the acquisition date, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent that the Company identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. |
Property and Equipment | Property and Equipment —Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for employee-related computers and software, three years for other office equipment and site-related computer hardware, and five years for furniture. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Down payments for property and equipment are recorded at cost and included in other assets in the accompanying consolidated balance sheet. Once the corresponding property and equipment item has been received, it will be reclassified to property and equipment and depreciated. |
Revenue Recognition | Revenue Recognition —The Company generates revenue from subscription-based arrangements and usage-based arrangements that allow customers to access its products and/or platform. The Company determines revenue recognition through the following steps: • identification of the contract, or contracts with a customer; • identification of the performance obligations in the contract; • determination of the transaction price; • allocation of the transaction price to the performance obligations in the contract; and • recognition of revenue, when, or as, the Company satisfies a performance obligation. Revenue from subscription-based arrangements is recognized on a ratable basis over the contractual subscription period of the arrangement beginning when or as control of the promised goods or services is transferred to the customer. Beginning in the second quarter of fiscal 2021, the Company started offering usage-based pricing to its customers. Customers have the option to be charged upon their incurred usage in arrears (“Pay as You Go”), or they may commit to a minimum spend over their contracted period. Revenue related to Pay as You Go contracts are recognized based on the customers’ actual usage. Revenue related to commitment contracts are recognized on a ratable basis over the contract period including an estimate of usage above the minimum commitment. Usage above minimum commitment is estimated by looking at usage in previous months and other factors and projecting out for the rest of the contract. The estimated usage-based revenues are constrained to the amount the Company expects to be entitled to receive in exchange for providing access to its platform. Deferred Revenue —Deferred revenue consists of billings or payments received in advance of revenue being recognized. The Company generally invoices its customers monthly, quarterly, or annually. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue and the remaining portion is recorded as non-current deferred revenue. The Company offers a comprehensive suite of products delivered on its open and extensible cloud-based platform that enable organizations to collect, store, and analyze massive amounts of data in real time so they can better operate their applications and infrastructure and improve their digital customer experience. The Company generates revenue from subscription-based arrangements and usage-based arrangements that allow customers to access its products and/or platform. Revenue from subscription-based arrangements is recognized on a ratable basis over the contractual subscription period of the arrangement beginning when or as control of the promised goods or services is transferred to the customer. Beginning in the second quarter of fiscal 2021, the Company started offering usage-based pricing to its customers. Customers have the option to be charged upon their incurred usage in arrears (“Pay as You Go”), or they may commit to a minimum spend over their contracted period. Revenue related to Pay as You Go contracts are recognized based on the customers’ actual usage. Revenue related to commitment contracts are recognized on a ratable basis over the contract period including an estimate of usage above the minimum commitment. Usage above minimum commitment is estimated by looking at usage in previous months and other factors and projecting out for the rest of the contract. The estimated usage-based revenues are constrained to the amount the Company expects to be entitled to receive in exchange for providing access to its platform. Deferred revenue consists of billings or payments received in advance of revenue being recognized. Disaggregation of Revenue For disaggregated revenue by geography, refer to Note 16—Revenue by Geographic Location. Contract Balances In a response to the COVID-19 pandemic, the Company performed additional procedures to evaluate the creditworthiness of its customers and assess collectability of accounts. Using a current expected credit loss model, the Company determined that, while there may be a delay in collections due to the downturn in economic activity, there has not been a material impact to the risk of credit loss on accounts receivables as of March 31, 2022. The Company receives payments from customers based upon billing cycles. As the Company performs under customer contracts, its right to consideration that is unconditional is considered to be accounts receivable. If the Company’s right to consideration for such performance is contingent upon a future event or satisfaction of additional performance obligations, the amount of revenues the Company has recognized in excess of the amount it has billed to the customer is considered to be a contract asset. Contract assets were $1.5 million and $2.5 million as of March 31, 2022 and March 31, 2021, respectively. The Company has no asset impairment charges related to contract assets for the periods presented. Deferred revenue represents consideration received from customers in excess of revenues recognized. Contract Acquisition Costs The Company capitalizes certain contract acquisition costs primarily consisting of commissions. The balances of deferred costs to obtain customer contracts were $34.5 million and $68.8 million as of March 31, 2022 and March 31, 2021, respectively. In the fiscal years ended March 31, 2022 and 2021, amortization from amounts capitalized was $36.6 million and $38.3 million, respectively. In the fiscal years ended March 31, 2022 and 2021, amounts expensed as incurred were $62.7 million and $14.5 million, respectively. The Company had no impairment loss in relation to costs capitalized. Remaining Performance Obligations The Company’s contracts with customers generally include one main performance obligation, which is access to its SaaS-based products and platform. Within the main performance obligation, each service is generally considered a distinct stand-ready obligation that is recognized over the contract term based on the passage of time. As of March 31, 2022, the aggregate unrecognized transaction price of remaining performance obligations was $706.1 million. The Company expects to recognize more than 96% of the balance as revenue in the 24 months following March 31, 2022 and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized and does not include contract amounts which are cancellable by the customer and amounts associated with optional renewal periods. |
Cost of Revenue | Cost of Revenue —Cost of revenue consists of expenses relating to data center operations, hosting-related costs, payment processing fees, depreciation and amortization, consulting costs, and salaries and benefits of operations and global customer support personnel. |
Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable and Allowance for Doubtful Accounts—Accounts receivable are recorded at the invoiced amount, net of allowances for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine whether a specific allowance is appropriate. Accounts receivable deemed uncollectable are charged against the allowance for doubtful accounts when identified. |
Software Development Costs | Software Development Costs —The Company capitalizes certain development costs incurred in connection with its internal use software and website. These capitalized costs are primarily related to its software tools that are hosted by the Company and accessed by its customers on a subscription basis. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases when the software is released or made available. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally three years. |
Commissions | Commissions—Previously the Company capitalized incremental commissions related to initial contracts and amortized such costs over the expected period of benefit, which the Company has determined to be three years, because the commissions paid upon renewal were not commensurate with the commissions paid on initial contracts. With our shift to a consumption model pricing strategy, a significant majority of commissions are no longer capitalized because commissions paid upon renewal are now commensurate and instead mostly expensed as incurred. Commissions expense is recorded in sales and marketing expense within the consolidated statement of operations. |
Advertising Expenses | Advertising Expenses—Advertising is expensed as incurred and is included in sales and marketing in the consolidated statements of operations. |
Operating Leases | Operating Leases —The Company leases office space under non-cancelable operating leases which expire from 2022 to 2031. All of its office leases are classified as operating leases with lease expense recognized on a straight-line basis over the lease term. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company considers information including, but not limited to, the lease term, the Company's credit rating and interest rates of similar debt instruments with comparable credit ratings. The lease right-of-use assets are also increased by any lease prepayments made and reduced by any lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain that the Company will exercise the extension option. The Company’s operating leases typically include nonlease components such as common-area maintenance costs. The Company has elected to include nonlease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Nonlease components that are not fixed are expensed as incurred as variable lease payments. Leases with a term of one year or less are not recognized on the Company’s consolidated balance sheet. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets—Long-lived assets, such as property and equipment, acquired intangible assets, and capitalized software development costs subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by the asset to its carrying value. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. |
Goodwill | Goodwill—Goodwill represents the excess of the purchase price of an acquired business over the fair value of the underlying net tangible and intangible assets. Goodwill is evaluated for impairment annually in the third quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. |
Intangible Assets | Intangible Assets —Intangible assets consist of identifiable intangible assets, primarily developed technology, resulting from the Company’s acquisitions. Acquired intangible assets are recorded at cost, net of accumulated amortization. Intangible assets are amortized on a straight-line basis over their estimated useful lives. |
Stock-Based Compensation | Stock-Based Compensation —The Company estimates the fair value of share-based awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the statements of operations. The Company recognizes compensation expense for the majority of its awards over the vesting period of the entire award using the straight-line attribution method. These amounts are reduced by an estimated forfeiture rate. The forfeiture rate is estimated based on actual cancellation experience and is applied to all share-based awards. The rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company selected the Black-Scholes option-pricing model as the method for determining the estimated fair value for stock options and shares pursuant to the Company’s 2014 Employee Stock Purchase Plan, or ESPP. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, which determine the fair value of share-based awards, including the option’s expected term and the price volatility of the underlying stock. The Company uses a Monte Carlo simulation model to determine the fair value of its performance stock units, or PSUs, and recognizes expense using the accelerated attribution method over the requisite service period. |
Fair Value Measurements | Fair Value Measurements —The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers the principal or most advantageous market in which to transact and the market-based risk. The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a |
Concentration of Risk | Concentration of Risk—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, short-term investments, and trade accounts receivable. The Company invests its excess cash in money market funds, certificates of deposit, commercial paper, U.S. treasury securities, U.S. agency securities, and corporate debt securities with major financial institutions. Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, are subject to minimal credit risk. |
Income Taxes | Income Taxes —The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. In addition, deferred tax assets are recorded for the future benefit of utilizing net operating losses and research and development credit carryforwards. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statement of operations. |
Net Loss Per Share | Net Loss Per Share—The Company’s basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period. For purposes of this calculation, options to purchase common stock, common stock reserved for issuance, restricted stock units, convertible debt, and shares issuable pursuant to the ESPP are considered common stock equivalents but have been excluded from the calculation of diluted net loss per share as their effect is antidilutive |
Recently Issued Accounting Pronouncements Not Yet Adopted and Recently Adopted Accounting Pronouncements | Recently Issued Accounting Pronouncements Not Yet Adopted In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses an issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This guidance is effective for the Company’s fiscal year beginning April 1, 2022. The Company is currently evaluating the impact of adopting this guidance. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations - Accounting for Contract Liabilities from Contracts with Customers (Topic 805), which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under ASC 606 as if the entity had originated the contracts. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of adopting this guidance. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The Company adopted ASU 2020-06 effective April 1, 2021, using the modified retrospective basis, which resulted in a $54.2 million decrease to the opening balance of accumulated deficit, a $100.1 million decrease to the opening balance of additional paid-in capital, and a $45.9 million increase to the opening balance of the Notes, net on the consolidated balance sheet. |
Business Combinations (Tables)
Business Combinations (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Aggregate Purchase Price Allocation | The following table presents the preliminary purchase price allocation related to the acquisition (in thousands): Cash consideration paid $ 15,140 Fair value of common shares issued 26,768 Total consideration 41,908 Post-business combination compensation expense (13,282) Total purchase price 28,626 Net assets assumed (113) Deferred tax liabilities 1,211 Developed technology acquired (10,300) Goodwill $ 19,424 The following table presents the purchase price allocation related to the acquisition (in thousands): Cash consideration paid $ 45,558 Fair value of common shares issued 114,310 Total consideration 159,868 Post-business combination compensation expense (51,943) Total purchase price 107,925 Net assets assumed (4,099) Deferred tax liabilities 115 Developed technology acquired (4,800) Goodwill $ 99,141 |
Joint Venture (Tables)
Joint Venture (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Schedule of Redeemable Non-Controlling Interest | The following table summarizes the activity in the redeemable non-controlling interest for the period indicated below: March 31, 2022 March 31, 2021 March 31, 2020 Balance, beginning of period $ 3,389 $ 1,669 $ 2,733 Investment by redeemable non-controlling interest — — 978 Net loss attributable to redeemable non-controlling interest (282) (1,421) (2,042) Adjustment to redeemable non-controlling interest 18,579 3,141 — Balance, end of period $ 21,686 $ 3,389 $ 1,669 |
Revenue from Contract with Cust
Revenue from Contract with Customer (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Deferred Revenue | The following table presents the changes to the Company’s deferred revenue (in thousands): March 31, 2022 March 31, 2021 Deferred revenue, beginning of period $ 375,268 $ 316,327 Contributions from contract asset (1,017) 2,446 Billings 810,132 724,143 Revenue recognized (785,521) (667,648) Deferred revenue, end of period $ 398,862 $ 375,268 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Information about Financial Assets Measured at Fair Value on Recurring Basis | The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2022 and 2021 based on the three-tier fair value hierarchy (in thousands): Fair Value Measurements as of March 31, 2022 Level 1 Level 2 Level 3 Total Cash and cash equivalents: Money market funds $ 109,327 $ — $ — $ 109,327 Short-term investments: Certificates of deposit — 126,885 — 126,885 Commercial paper — 27,861 — 27,861 Corporate notes and bonds — 85,065 — 85,065 U.S. treasury securities 320,173 — — 320,173 Restricted cash: Money market funds 5,775 — — 5,775 Total $ 435,275 $ 239,811 $ — $ 675,086 Included in cash and cash equivalents $ 109,327 Included in short-term investments $ 559,984 Included in restricted cash $ 5,775 Fair Value Measurements as of March 31, 2021 Level 1 Level 2 Level 3 Total Cash and cash equivalents: Money market funds $ 101,626 $ — $ — $ 101,626 Short-term investments: Certificates of deposit — 48,099 — 48,099 Commercial paper — 11,681 — 11,681 Corporate notes and bonds — 39,873 — 39,873 U.S. treasury securities 475,601 — — 475,601 Restricted cash: Money market funds 5,642 — — 5,642 Total $ 582,869 $ 99,653 $ — $ 682,522 Included in cash and cash equivalents $ 101,626 Included in short-term investments $ 575,254 Included in restricted cash $ 5,642 |
Schedule of Debt Securities, Available-for-sale | The following table presents our available-for-sale securities as of March 31, 2022 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Short-term investments: Certificates of deposit $ 127,500 $ — $ (615) $ 126,885 Commercial paper 27,946 — (85) 27,861 Corporate notes and bonds 87,259 — (2,194) 85,065 U.S. treasury securities 323,584 79 (3,490) 320,173 Total available-for-sale investments $ 566,289 $ 79 $ (6,384) $ 559,984 The following table presents the Company’s available-for-sale securities as of March 31, 2021 (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Short-term investments: Certificates of deposit $ 48,100 $ 18 $ (19) $ 48,099 Commercial paper 11,676 5 — 11,681 Corporate notes and bonds 39,620 261 (8) 39,873 U.S. treasury securities 474,171 1,575 (145) 475,601 Total available-for-sale investments $ 573,567 $ 1,859 $ (172) $ 575,254 |
Classification of Available-for-Sale Short-Term Investments by Contractual Maturities | The following table classifies the Company’s available-for-sale short-term investments by contractual maturities as of March 31, 2022 and 2021 (in thousands): March 31, 2022 March 31, 2021 Due within one year $ 354,774 $ 299,032 Due after one year and within three years 205,210 276,222 Total $ 559,984 $ 575,254 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment, Net | Property and equipment, net, consisted of the following (in thousands): March 31, 2022 March 31, 2021 Computers, software, and equipment $ 13,854 $ 14,270 Site operation equipment 67,726 87,479 Furniture and fixtures 5,772 5,758 Leasehold improvements 49,756 49,751 Capitalized software development costs 79,808 66,451 Total property and equipment 216,916 223,709 Less: accumulated depreciation and amortization (148,548) (132,401) Total property and equipment, net $ 68,368 $ 91,308 |
0.5% Convertible Senior Notes_2
0.5% Convertible Senior Notes and Capped Call (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Summary of Convertible Debt | The net carrying amount of the liability component of the Notes as of March 31, 2022 and 2021 was as follows (in thousands): March 31, 2022 March 31, 2021 Principal $ 500,250 $ 500,250 Unamortized debt discount — (46,378) Unamortized issuance costs (2,587) (4,492) Net carrying amount $ 497,663 $ 449,380 |
Summary of Interest Expense | Interest expense related to the Notes is as follows (in thousands): March 31, 2022 March 31, 2021 Amortization of debt discount $ — $ 20,516 Amortization of issuance costs 2,357 1,820 Contractual interest expense 2,496 2,501 Total interest expense $ 4,853 $ 24,837 |
Goodwill and Purchased Intang_2
Goodwill and Purchased Intangibles Assets (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The changes in the carrying amount of goodwill for the twelve months ended March 31, 2022 consisted of the following (in thousands): Goodwill as of March 31, 2021 $ 144,253 Goodwill acquired 19,424 Goodwill as of March 31, 2022 $ 163,677 |
Schedule of Purchased Intangible Assets Subject to Amortization | Purchased intangible assets subject to amortization as of March 31, 2022 consisted of the following (in thousands): Gross Carrying Accumulated Net Carrying Developed technology $ 27,500 $ (11,864) $ 15,636 Purchased intangible assets subject to amortization as of March 31, 2021 consisted of the following (in thousands): Gross Carrying Accumulated Net Carrying Developed technology $ 20,116 $ (7,130) $ 12,986 |
Schedule of Estimated Future Amortization Expense | Estimated future amortization expense as of March 31, 2022 is as follows (in thousands): Fiscal Years Ending March 31, Estimated Future Amortization Expense 2023 $ 9,000 2024 4,633 2025 2,003 $ 15,636 |
Other Current Liabilities (Tabl
Other Current Liabilities (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Other Liabilities Disclosure [Abstract] | |
Summary of Other Current Liabilities | Other current liabilities consisted of the following (in thousands): As of March 31, 2022 2021 Accrued liabilities $ 4,145 $ 4,050 Accrued tax liabilities 1,196 1,042 Other 30,757 14,082 Total other current liabilities $ 36,098 $ 19,174 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Schedule of Condensed Consolidated Balance Sheet | The following table presents information about leases on the consolidated balance sheet (in thousands): March 31, 2022 March 31, 2021 Assets Lease right-of-use-assets $ 50,465 $ 57,425 Liabilities Lease liabilities $ 11,103 $ 7,886 Lease liabilities, non-current 49,809 59,924 Total operating lease liabilities $ 60,912 $ 67,810 |
Schedule of Condensed Consolidated Statement of Operations and Supplemental Cash Flow Information | The following table presents information about leases on its consolidated statement of operations (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Operating lease expense $ 13,579 $ 13,870 $ 14,220 Short-term lease expense 832 843 1,074 Variable lease expense 2,872 2,581 2,682 The following table presents supplemental cash flow information about the Company’s leases (in thousands): Fiscal Year Ended March 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities $ 13,949 $ 15,666 Operating lease assets obtained in exchange for new lease liabilities (1) 2,611 8,525 (1) Includes the impact of new leases as well as remeasurements and modifications to existing leases. |
Summary of Remaining Maturities of Lease Liabilities | As of March 31, 2022, remaining maturities of lease liabilities were as follows (in thousands): Fiscal Years Ending March 31, Operating Leases 2023 $ 14,750 2024 14,118 2025 11,592 2026 11,795 2027 12,380 Thereafter 8,336 Total operating lease payments $ 72,971 Less imputed interest (12,059) Total operating lease liabilities $ 60,912 |
Common Stock and Stockholders_2
Common Stock and Stockholders' Equity (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Equity [Abstract] | |
Schedule of Shares of Common Stock Reserved for Future Issuance | The Company had reserved shares of common stock for future issuance pursuant to equity plans as follows (in thousands): As of March 31, 2022 2021 Common stock options outstanding 1,663 2,718 RSUs outstanding 3,351 3,293 PSUs outstanding 320 112 Available for future stock option, RSU, and PSU grants 13,904 12,281 Available for future employee stock purchase plan awards 2,988 2,702 22,226 21,106 |
Schedule of Stock Option, RSU and PSU, and Time-Based Restricted Stock Activity | The following table summarizes the Company’s stock option, restricted stock unit (“RSU”), and performance unit (“PSU”) award activities for the fiscal year ended March 31, 2022 (in thousands, except exercise price, contractual term and fair value information): Options Outstanding RSUs Outstanding PSUs Outstanding Number of Shares Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value Number of Weighted- Weighted- Aggregate Number of Weighted- Weighted- Aggregate Outstanding—April 1, 2021 2,718 $ 50.55 6.2 $ 48,064 3,293 $ 67.76 2.8 $ 202,459 112 $ 99.05 2.0 $ 6,884 Granted (1) — — 2,710 69.94 241 82.89 Exercised/vested (848) 37.56 39,003 (1,472) 67.32 (33) 99.05 Canceled/forfeited (207) 70.77 (1,180) 66.83 — Outstanding - March 31, 2022 1,663 $ 54.66 5.6 $ 31,436 3,351 $ 70.04 2.6 $ 224,096 320 $ 86.88 1.8 $ 21,430 Options vested and expected to vest - March 31, 2022 1,662 $ 54.65 5.6 $ 31,436 Options vested and exercisable - March 31, 2022 1,310 $ 50.66 5.0 $ 30,233 RSUs and PSUs expected to vest - March 31, 2022 3,173 $ 69.54 $ 212,235 305 $ 87.00 $ 20,370 (1) The above table includes 241,398 performance unit awards and does not include any time-based restricted stock issued as consideration for an acquisition which are further detailed in the table below. The following table summarizes the time-based restricted stock issued as consideration for an acquisition during the fiscal years ended March 31, 2022, 2021, and 2020: Fiscal Years Ending March 31, Number of Shares of Time-Based Restricted Stock Granted as Consideration for Acquisitions 2020 — 2021 736,469 (1) 2022 199,492 (2) (1) These shares were issued in connection with the Pixie Labs acquisition, which included a holdback arrangement with certain employees of Pixie Labs. These shares are subject to the recipients’ continued service and will be recognized as stock-based compensation expense over the vesting periods, which range from 18 months to 37 months from the closing date of the acquisition. (2) These shares were issued in connection with the CodeStream acquisition, which included a holdback arrangement with certain employees of CodeStream. These shares are subject to the recipients’ continued service and will be recognized as stock-based compensation expense over the vesting periods, which range from 18 months to 42 months from the closing date of the acquisition. |
Schedule of Assumptions Used to Estimate Fair Value of Stock Options Granted and ESPP Shares to be Issued | The assumptions used to estimate the fair value of stock options granted and ESPP shares to be issued during the fiscal years ended March 31, 2022, 2021, and 2020 were as follows: Stock Options: Fiscal Year Ended March 31, 2022 2021 2020 Expected term (years) 0 6 6 Expected volatility 0 - 0% 44 - 46% 41 - 42% Risk-free interest rate 0.00 - 0.00% 0.34 - 0.76% 1.45 - 3.06% Dividend yield — — — ESPP: Fiscal Year Ended March 31, 2022 2021 2020 Expected term (years) 0.5 0.5 0.5 Expected volatility 38 - 76% 55 - 76% 33 - 60% Risk-free interest rate 0.05 - 0.72% 0.06 - 0.12% 1.56 - 1.86% Dividend yield — — — |
Schedule of Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses | Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Cost of revenue $ 5,042 $ 5,939 $ 5,303 Research and development 48,355 40,964 31,703 Sales and marketing 48,986 54,695 43,548 General and administrative (1) 50,656 33,545 18,982 Total stock-based compensation expense (2) $ 153,039 $ 135,143 $ 99,536 (1) Includes $9.6 million acceleration of share-based payment expense for the fiscal year ended March 31, 2022, for one of the Company’s executives due to his departure at the end of June 2021. (2) Includes $0.5 million expense for the fiscal year ended March 31, 2022, due to the restructuring activities commenced in the first quarter of fiscal 2022. Refer to Note 18. Restructuring for more information. |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Components of (Loss) Income Before Income Taxes | The components of income (loss) before income taxes were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Domestic $ (238,068) $ (193,262) $ (93,687) Foreign 6,286 2,931 2,919 Total $ (231,782) $ (190,331) $ (90,768) |
Components of Provision (Benefit) for Income Taxes | The components of the provision for income taxes were as follows (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 Current Provision: Federal $ — $ — $ (1,177) State 276 (9) 34 Foreign 1,385 685 1,632 Total current provision 1,661 676 489 Deferred Provision: Federal (1,120) 35 — State (64) (96) — Foreign (154) (56) (278) Total deferred provision (1,338) (117) (278) Total income tax provision $ 323 $ 559 $ 211 |
Schedule of Effective Federal Statutory Rate and Provision for Income Taxes | The items accounting for the difference between income taxes computed at the federal statutory rate and the provision for income taxes consisted of the following: Fiscal Year Ended March 31, 2022 2021 2020 Federal statutory rate 21.0 % 21.0 % 21.0 % Effect of: State taxes, net of federal benefits 3.5 3.0 3.0 Stock-based compensation 3.8 (1.5) (0.4) Research and development credits, net of ASC 740-10 2.5 2.4 5.1 Permanent items (4.4) (2.4) (4.0) Foreign taxes — 0.2 0.4 Intraperiod allocation — — 1.5 Other 0.5 0.7 0.7 Valuation allowance (27.0) (23.7) (27.5) Effective tax rate (0.1) % (0.3) % (0.2) % |
Schedule of Deferred Tax Assets and Liabilities | The following table presents the significant components of the Company’s deferred tax assets and liabilities for the periods presented (in thousands): As of March 31, 2022 2021 Deferred tax assets: Accrued expenses $ 2,568 $ 3,429 Depreciation and amortization 5,657 3,518 Capitalized research and development 24,050 — Net operating loss and other attribute carryforwards 196,159 178,535 Stock based compensation 20,695 14,987 Research and development credits 31,695 25,932 Lease liability 13,349 15,208 Convertible debt 3,638 — Other 4,530 378 Gross deferred tax assets 302,341 241,987 Valuation allowance (276,475) (198,794) Total deferred tax assets 25,866 43,193 Deferred tax liabilities: Prepaids (4,268) (3,949) Intangibles (2,679) (1,923) Capitalized research and development — (4,405) Deferred contract acquisition costs (7,326) (15,520) Convertible debt — (3,991) Right of use asset (10,809) (12,748) Total deferred tax liabilities (25,082) (42,536) Total net deferred tax assets/(liabilities) $ 784 $ 657 |
Schedule of Unrecognized Tax Benefits Reconciliation | Balance at March 31, 2019 $ 7,997 Additions based on tax positions taken during the current period 2,183 Additions based on tax positions taken during the prior period 687 Reductions based on tax positions taken during the prior period (529) Balance at March 31, 2020 10,338 Additions based on tax positions taken during the current period 2,667 Additions based on tax positions taken during the prior period 703 Reductions based on tax positions taken during the prior period (1,549) Balance at March 31, 2021 12,159 Additions based on tax positions taken during the current period 2,920 Additions based on tax positions taken during the prior period 430 Reductions based on tax positions taken during the prior period (521) Balance at March 31, 2022 $ 14,988 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Computation of Net Loss Per Share Attributable to Common Stockholders, Basic and Diluted | The following table sets forth the computation of net loss per share, basic and diluted (in thousands, except per share amounts): Fiscal Year Ended March 31, 2022 2021 2020 Numerator: Net loss attributable to New Relic $ (250,402) $ (192,610) $ (88,937) Denominator: Weighted average shares used to compute net loss per share, basic and diluted 64,592 61,070 58,601 Net loss attributable to New Relic per share—basic and diluted $ (3.88) $ (3.15) $ (1.52) |
Antidilutive Securities Excluded from Computation of Diluted Net Loss per Common Share of Common Stock Equivalents | The following outstanding options, unvested shares, and ESPP shares were excluded (as common stock equivalents) from the computation of diluted net loss per common share for the periods presented as their effect would have been antidilutive (in thousands): As of March 31, 2022 2021 2020 Options to purchase common stock 1,663 2,718 2,850 RSUs 3,351 3,293 3,100 PSUs 320 112 — ESPP shares 45 48 69 5,379 6,171 6,019 |
Revenue by Geographic Location
Revenue by Geographic Location (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Revenue by Geographic Areas | The following table shows the Company’s revenue by geographic areas, as determined based on the billing address of its customers (in thousands): Fiscal Year Ended March 31, 2022 2021 2020 United States $ 528,922 $ 460,944 $ 417,827 EMEA 121,301 104,184 98,651 APAC 79,940 62,590 50,831 Other 55,358 39,930 32,201 Total revenue $ 785,521 $ 667,648 $ 599,510 |
Restructuring (Tables)
Restructuring (Tables) | 12 Months Ended |
Mar. 31, 2022 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Rescheduling Charges | The following table shows the Company’s restructuring charges for the fiscal year ended March 31, 2022 (in thousands): Fiscal Year Ended March 31, 2022 Severance and other employee costs Stock-based compensation Asset impairment Total Sales and marketing $ 10,819 $ 406 $ 104 $ 11,329 General and administrative 1,170 87 26 1,283 Total $ 11,989 $ 493 $ 130 $ 12,612 |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Detail) $ in Thousands | 12 Months Ended | |||
Mar. 31, 2022USD ($)Segment | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Apr. 01, 2021USD ($) | |
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Reportable segments | Segment | 1 | |||
Gross value of capitalized internal use software | $ 16,400 | $ 17,600 | $ 8,100 | |
Stock-based compensation costs | 3,700 | 4,100 | 1,500 | |
Amortization expense | 10,700 | 7,000 | 4,900 | |
Net book value of capitalized software | 28,000 | 23,200 | ||
Capitalized implementation costs | 1,600 | 2,100 | 2,500 | |
Amortization expense | 1,300 | 1,200 | 200 | |
Accumulated deficit | (783,308) | (587,116) | ||
Convertible senior notes, net | 497,663 | 449,380 | ||
Accounting Standards Update 2020-06 | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Accumulated deficit | $ 54,200 | |||
Decrease to additional paid in capital | 100,100 | |||
Convertible senior notes, net | $ 45,900 | |||
Sales and marketing | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Advertising expense | $ 29,000 | $ 24,500 | $ 21,800 | |
Computers and Software | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Property plant and equipment estimated useful life | 3 years | |||
Other Office Equipment and Site-related Computer Hardware | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Property plant and equipment estimated useful life | 3 years | |||
Furniture and Fixtures | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Property plant and equipment estimated useful life | 5 years | |||
Capitalized Software Development Costs | ||||
Description Of Business And Summary Of Significant Accounting Policies [Line Items] | ||||
Property plant and equipment estimated useful life | 3 years |
Business Combinations - Narrati
Business Combinations - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | Jun. 08, 2021 | Dec. 22, 2020 | Oct. 31, 2019 | Mar. 31, 2021 | Mar. 31, 2022 |
Business Acquisition [Line Items] | |||||
Preliminary purchase price allocation, goodwill | $ 144,253 | $ 163,677 | |||
CodeStream Inc. | |||||
Business Acquisition [Line Items] | |||||
Business acquisition, aggregate purchase price | $ 28,626 | ||||
Cash consideration paid | 15,140 | ||||
Cash held in escrow | $ 7,300 | ||||
Escrow period | 18 months | ||||
Number of shares issued to acquire capital stock (in shares) | 202,561,000,000 | ||||
Fair value of common shares issued | $ 13,500 | ||||
Fair value of shares issued to acquire capital stock (in usd per share) | $ 66.58 | ||||
Holdback arrangement, common stock (in shares) | 199,492 | ||||
Amount excluded from the aggregate purchase price | $ 13,300 | ||||
Vesting period | 42 months | ||||
Preliminary purchase price allocation, goodwill | $ 19,424 | ||||
CodeStream Inc. | Technology | |||||
Business Acquisition [Line Items] | |||||
Acquired technology, estimated useful life | 3 years | ||||
Acquired technology | $ 10,300 | ||||
Pixie Labs Inc. | |||||
Business Acquisition [Line Items] | |||||
Business acquisition, aggregate purchase price | $ 107,925 | ||||
Cash consideration paid | 45,558 | ||||
Cash held in escrow | $ 15,000 | ||||
Escrow period | 12 months | ||||
Number of shares issued to acquire capital stock (in shares) | 884,269 | ||||
Fair value of common shares issued | $ 62,400 | ||||
Fair value of shares issued to acquire capital stock (in usd per share) | $ 70.53 | ||||
Holdback arrangement, common stock (in shares) | 736,469 | ||||
Amount excluded from the aggregate purchase price | $ 51,900 | ||||
Total direct transaction costs | $ 900 | ||||
Acquisition-related expenses | 600 | ||||
Preliminary purchase price allocation, goodwill | $ 99,141 | ||||
Pixie Labs Inc. | Minimum | |||||
Business Acquisition [Line Items] | |||||
Vesting period | 18 months | ||||
Pixie Labs Inc. | Maximum | |||||
Business Acquisition [Line Items] | |||||
Vesting period | 37 months | ||||
Pixie Labs Inc. | Technology | |||||
Business Acquisition [Line Items] | |||||
Acquired technology, estimated useful life | 3 years | ||||
IOpipe, Inc. | |||||
Business Acquisition [Line Items] | |||||
Cash consideration paid | $ 5,100 | ||||
Amount excluded from the aggregate purchase price | 900 | ||||
Preliminary purchase price allocation, goodwill | $ 3,600 | ||||
IOpipe, Inc. | Technology | |||||
Business Acquisition [Line Items] | |||||
Acquired technology, estimated useful life | 3 years | ||||
Acquired technology | $ 1,500 |
Business Combinations - Schedul
Business Combinations - Schedule of Aggregate Purchase Price Allocation (Details) - USD ($) $ in Thousands | Jun. 08, 2021 | Dec. 22, 2020 | Mar. 31, 2022 | Mar. 31, 2021 |
Business Acquisition [Line Items] | ||||
Goodwill | $ 163,677 | $ 144,253 | ||
CodeStream Inc. | ||||
Business Acquisition [Line Items] | ||||
Cash consideration paid | $ 15,140 | |||
Fair value of common shares issued | 26,768 | |||
Total consideration | 41,908 | |||
Post-business combination compensation expense | (13,282) | |||
Total purchase price | 28,626 | |||
Net assets assumed | (113) | |||
Deferred tax liabilities | 1,211 | |||
Developed technology acquired | (10,300) | |||
Goodwill | $ 19,424 | |||
Pixie Labs Inc. | ||||
Business Acquisition [Line Items] | ||||
Cash consideration paid | $ 45,558 | |||
Fair value of common shares issued | 114,310 | |||
Total consideration | 159,868 | |||
Post-business combination compensation expense | (51,943) | |||
Total purchase price | 107,925 | |||
Net assets assumed | (4,099) | |||
Deferred tax liabilities | 115 | |||
Developed technology acquired | (4,800) | |||
Goodwill | $ 99,141 |
Joint Venture - Additional Info
Joint Venture - Additional Information (Details) ¥ in Millions, $ in Millions | Aug. 21, 2019USD ($) | Aug. 21, 2019JPY (¥) | Aug. 21, 2018USD ($) | Aug. 21, 2018JPY (¥) | Mar. 31, 2022USD ($) | Aug. 21, 2019JPY (¥) |
Schedule of Equity Method Investments [Line Items] | ||||||
Additional investor contribution | $ 1.5 | ¥ 156 | ||||
Redemption value of redeemable non-controlling interest | $ 18.6 | |||||
The Investors | ||||||
Schedule of Equity Method Investments [Line Items] | ||||||
Contributions for joint venture | $ 1 | ¥ 104 | $ 3.6 | ¥ 396 | ||
New Relic K.K | The Investors | ||||||
Schedule of Equity Method Investments [Line Items] | ||||||
Ownership percentage, noncontrolling interest | 40.00% | 40.00% | 60.00% |
Joint Venture - Schedule of Red
Joint Venture - Schedule of Redeemable Non-Controlling Interest (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Increase (Decrease) in Temporary Equity [Roll Forward] | |||
Balance, beginning of period | $ 3,389 | $ 1,669 | $ 2,733 |
Investment by redeemable non-controlling interest | 0 | 0 | 978 |
Net loss attributable to redeemable non-controlling interest | (282) | (1,421) | (2,042) |
Adjustment to redeemable non-controlling interest | 18,579 | 3,141 | 0 |
Balance, end of period | $ 21,686 | $ 3,389 | $ 1,669 |
Revenue - Additional Informatio
Revenue - Additional Information (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | ||
Contract assets | $ 1,500,000 | $ 2,500,000 |
Percentage of revenue recognized | 47.00% | 47.00% |
Revenue recognized from performance obligations satisfied in prior periods | $ 9,800,000 | $ 0 |
Recognition of capitalized contract costs, due to adoption of new accounting guidance | 34,500,000 | 68,800,000 |
Capitalized contract cost, amortization | 36,600,000 | 38,300,000 |
Acquisition costs expensed as incurred | 62,700,000 | 14,500,000 |
Contract asset impairment | $ 0 | $ 0 |
Revenue - Summary of Deferred R
Revenue - Summary of Deferred Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Contract With Customer, Contract Liability Rollforward [Roll Forward] | ||
Deferred revenue, beginning of period | $ 375,268 | $ 316,327 |
Contributions from contract asset | (1,017) | 2,446 |
Billings | 810,132 | 724,143 |
Revenue recognized | (785,521) | (667,648) |
Deferred revenue, end of period | $ 398,862 | $ 375,268 |
Revenue - Remaining Performance
Revenue - Remaining Performance Obligations (Details) $ in Millions | Mar. 31, 2022USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 706.1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, percentage | 96.00% |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 24 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, percentage | 4.00% |
Revenue, remaining performance obligation, expected timing of satisfaction, period |
Fair Value Measurements - Infor
Fair Value Measurements - Information about Financial Assets Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | $ 675,086 | $ 682,522 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 435,275 | 582,869 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 239,811 | 99,653 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 109,327 | 101,626 |
Cash and cash equivalents | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 109,327 | 101,626 |
Cash and cash equivalents | Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 109,327 | 101,626 |
Cash and cash equivalents | Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Cash and cash equivalents | Level 3 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 559,984 | 575,254 |
Short-term investments | Certificates of deposit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 126,885 | 48,099 |
Short-term investments | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 27,861 | 11,681 |
Short-term investments | Corporate notes and bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 85,065 | 39,873 |
Short-term investments | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 320,173 | 475,601 |
Short-term investments | Level 1 | Certificates of deposit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 1 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 1 | Corporate notes and bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 1 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 320,173 | 475,601 |
Short-term investments | Level 2 | Certificates of deposit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 126,885 | 48,099 |
Short-term investments | Level 2 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 27,861 | 11,681 |
Short-term investments | Level 2 | Corporate notes and bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 85,065 | 39,873 |
Short-term investments | Level 2 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 3 | Certificates of deposit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 3 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 3 | Corporate notes and bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Short-term investments | Level 3 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Restricted cash | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 5,775 | 5,642 |
Restricted cash | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 5,775 | 5,642 |
Restricted cash | Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 5,775 | 5,642 |
Restricted cash | Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | 0 | 0 |
Restricted cash | Level 3 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets fair value | $ 0 | $ 0 |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Debt Securities Available-for-sale (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 566,289 | $ 573,567 |
Unrealized Gains | 79 | 1,859 |
Unrealized Losses | (6,384) | (172) |
Fair Value | 559,984 | 575,254 |
Certificates of deposit | Short-term investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 127,500 | 48,100 |
Unrealized Gains | 0 | 18 |
Unrealized Losses | (615) | (19) |
Fair Value | 126,885 | 48,099 |
Commercial paper | Short-term investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 27,946 | 11,676 |
Unrealized Gains | 0 | 5 |
Unrealized Losses | (85) | 0 |
Fair Value | 27,861 | 11,681 |
Corporate notes and bonds | Short-term investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 87,259 | 39,620 |
Unrealized Gains | 0 | 261 |
Unrealized Losses | (2,194) | (8) |
Fair Value | 85,065 | 39,873 |
U.S. treasury securities | Short-term investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 323,584 | 474,171 |
Unrealized Gains | 79 | 1,575 |
Unrealized Losses | (3,490) | (145) |
Fair Value | $ 320,173 | $ 475,601 |
Fair Value Measurements - Class
Fair Value Measurements - Classification of Available-for-Sale Short-Term Investments by Contractual Maturities (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract] | ||
Due within one year | $ 354,774 | $ 299,032 |
Due after one year and within three years | 205,210 | 276,222 |
Total | $ 559,984 | $ 575,254 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Detail) - Convertible Senior Notes Due 2023 - Convertible Debt - USD ($) $ in Millions | Mar. 31, 2022 | May 31, 2018 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Stated interest rate | 0.50% | 0.50% |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of Notes | $ 455 |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 216,916 | $ 223,709 |
Less: accumulated depreciation and amortization | (148,548) | (132,401) |
Total property and equipment, net | 68,368 | 91,308 |
Computers, software, and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 13,854 | 14,270 |
Site operation equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 67,726 | 87,479 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 5,772 | 5,758 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 49,756 | 49,751 |
Capitalized software development costs | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 79,808 | $ 66,451 |
Property and Equipment (Detail)
Property and Equipment (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Property, Plant and Equipment [Abstract] | |||
Depreciation and amortization expense | $ 40.5 | $ 44.3 | $ 41.1 |
0.5% Convertible Senior Notes_3
0.5% Convertible Senior Notes and Capped Call (Details) | 1 Months Ended | |||
May 31, 2018USD ($)day$ / shares | Mar. 31, 2022USD ($) | Apr. 01, 2021USD ($) | Mar. 31, 2021USD ($) | |
Debt Instrument [Line Items] | ||||
Accumulated deficit | $ (783,308,000) | $ (587,116,000) | ||
Convertible senior notes, net | $ 497,663,000 | 449,380,000 | ||
Purchase of capped calls | $ 63,200,000 | |||
Accounting Standards Update 2020-06 | ||||
Debt Instrument [Line Items] | ||||
Accumulated deficit | $ 54,200,000 | |||
Decrease to additional paid in capital | 100,100,000 | |||
Convertible senior notes, net | $ 45,900,000 | |||
Capped Calls | ||||
Debt Instrument [Line Items] | ||||
Convertible debt, conversion price (in dollars per share) | $ / shares | $ 110.81 | |||
Initial cap price (in dollars per share) | $ / shares | $ 173.82 | |||
Additional Paid-In Capital | Capped Calls | ||||
Debt Instrument [Line Items] | ||||
Costs incurred in connection with capped calls | $ 63,200,000 | |||
Convertible Debt | Convertible Senior Notes Due 2023 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument face amount | $ 500,250,000 | |||
Stated interest rate | 0.50% | 0.50% | ||
Convertible debt, conversion ratio | 9.0244 | |||
Convertible debt, conversion price (in dollars per share) | $ / shares | $ 110.81 | |||
Debt conversion option | $ 102,500,000 | |||
Effective interest rate | 5.74% | |||
Issuance costs | $ 11,600,000 | $ 2,587,000 | $ 4,492,000 | |
Debt issuance costs, equity component | 9,200,000 | |||
Issuance costs attributable to the equity component | 2,400,000 | |||
Conversion option | 102,500,000 | |||
Convertible Debt | Convertible Senior Notes Due 2023, Over-Allotment Option | ||||
Debt Instrument [Line Items] | ||||
Debt instrument face amount | $ 65,250,000 | |||
Convertible Debt | Stock Price Trigger Measurement | ||||
Debt Instrument [Line Items] | ||||
Threshold trading days | day | 20 | |||
Threshold consecutive trading days | day | 30 | |||
Threshold percentage of stock price trigger (less than) | 130.00% | |||
Convertible Debt | Notes Price Trigger Measurement | ||||
Debt Instrument [Line Items] | ||||
Threshold trading days | day | 5 | |||
Threshold consecutive trading days | day | 5 | |||
Threshold percentage of stock price trigger (less than) | 98.00% |
0.5% Convertible Senior Notes_4
0.5% Convertible Senior Notes and Capped Call - Schedule of Liability Component of Convertible Debt (Details) - Convertible Debt - Convertible Senior Notes Due 2023 - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 | May 31, 2018 |
Debt Instrument [Line Items] | |||
Principal | $ 500,250 | $ 500,250 | |
Unamortized debt discount | 0 | (46,378) | |
Unamortized issuance costs | (2,587) | (4,492) | $ (11,600) |
Net carrying amount | $ 497,663 | $ 449,380 |
0.5% Convertible Senior Notes_5
0.5% Convertible Senior Notes and Capped Call - Schedule of Interest Expense (Details) - Convertible Debt - Convertible Senior Notes Due 2023 - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Debt Instrument [Line Items] | ||
Amortization of debt discount | $ 0 | $ 20,516 |
Amortization of issuance costs | 2,357 | 1,820 |
Contractual interest expense | 2,496 | 2,501 |
Total interest expense | $ 4,853 | $ 24,837 |
Goodwill and Purchased Intang_3
Goodwill and Purchased Intangibles Assets - Schedule of Goodwill (Details) $ in Thousands | 12 Months Ended |
Mar. 31, 2022USD ($) | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill as of March 31, 2021 | $ 144,253 |
Goodwill acquired | 19,424 |
Goodwill as of March 31, 2022 | $ 163,677 |
Goodwill and Purchased Intang_4
Goodwill and Purchased Intangibles Assets - Schedule of Purchased Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Net Carrying Amount | $ 15,636 | $ 12,986 |
Developed technology | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 27,500 | 20,116 |
Accumulated Amortization | (11,864) | (7,130) |
Net Carrying Amount | $ 15,636 | $ 12,986 |
Goodwill and Purchased Intang_5
Goodwill and Purchased Intangibles Assets - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Amortization expense | $ 7.6 | $ 5.5 | $ 1.7 |
Goodwill and Purchased Intang_6
Goodwill and Purchased Intangibles Assets - Schedule of Estimated Future Amortization Expense (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Estimated Future Amortization Expense | ||
2023 | $ 9,000 | |
2024 | 4,633 | |
2025 | 2,003 | |
Net Carrying Amount | $ 15,636 | $ 12,986 |
Other Current Liabilities (Deta
Other Current Liabilities (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Other Liabilities Disclosure [Abstract] | ||
Accrued liabilities | $ 4,145 | $ 4,050 |
Accrued tax liabilities | 1,196 | 1,042 |
Other | 30,757 | 14,082 |
Total other current liabilities | $ 36,098 | $ 19,174 |
Leases - Assets and Liabilities
Leases - Assets and Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Assets | ||
Lease right-of-use assets | $ 50,465 | $ 57,425 |
Liabilities | ||
Lease liabilities | 11,103 | 7,886 |
Lease liabilities, non-current | 49,809 | 59,924 |
Total operating lease liabilities | $ 60,912 | $ 67,810 |
Leases - Narrative (Details)
Leases - Narrative (Details) | Mar. 31, 2022 |
Leases [Abstract] | |
Weighted average remaining lease term | 5 years 3 months 18 days |
Weighted average discount rate | 6.80% |
Leases - Expense (Details)
Leases - Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Leases [Abstract] | |||
Operating lease expense | $ 13,579 | $ 13,870 | $ 14,220 |
Short-term lease expense | 832 | 843 | 1,074 |
Variable lease expense | $ 2,872 | $ 2,581 | $ 2,682 |
Leases - Cash Flow Information
Leases - Cash Flow Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Leases [Abstract] | ||
Cash paid for amounts included in the measurement of lease liabilities | $ 13,949 | $ 15,666 |
Operating lease assets obtained in exchange for new lease liabilities | $ 2,611 | $ 8,525 |
Leases - Operating Lease Maturi
Leases - Operating Lease Maturity Schedule (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Leases [Abstract] | ||
2023 | $ 14,750 | |
2024 | 14,118 | |
2025 | 11,592 | |
2026 | 11,795 | |
2027 | 12,380 | |
Thereafter | 8,336 | |
Total operating lease payments | 72,971 | |
Less imputed interest | (12,059) | |
Total operating lease liabilities | $ 60,912 | $ 67,810 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions | 1 Months Ended | ||
Sep. 30, 2020 | Mar. 31, 2022 | Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Purchase commitments | $ 549.4 | $ 494.6 | |
Minimum commitment period | 5 years | ||
Minimum commitment amount | $ 500 |
Common Stock and Stockholders_3
Common Stock and Stockholders' Equity - Schedule of Shares of Common Stock Reserved for Future Issuance (Detail) - shares shares in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 22,226 | 21,106 |
RSUs outstanding | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 3,351 | 3,293 |
PSUs outstanding | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 320 | 112 |
Available for future stock option, RSU, and PSU grants | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 13,904 | 12,281 |
Available for future employee stock purchase plan awards | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 2,988 | 2,702 |
Common stock options outstanding | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 1,663 | 2,718 |
Common Stock and Stockholders_4
Common Stock and Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | Apr. 30, 2022 | Dec. 31, 2014 | Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 |
Class of Stock [Line Items] | |||||
Stock-based compensation expense | $ 153,039 | $ 135,143 | $ 99,536 | ||
Shares available for issuance (in shares) | 22,226,000 | 21,106,000 | |||
Weighted-average grant-date fair value of options granted (in usd per share) | $ 0 | $ 26.51 | $ 30.67 | ||
Intrinsic value of options exercised | $ 39,003 | ||||
Total fair value of RSUs vested | $ 99,300 | $ 107,100 | $ 63,300 | ||
Closing stock price reported (in usd per share) | $ 66.88 | ||||
Unrecognized stock-based compensation cost related to outstanding unvested stock awards | $ 9,800 | ||||
Stock-based compensation cost expected to be recognized over weighted-average period | 1 year 9 months 18 days | ||||
Expected to vest unrecognized stock-based compensation cost related to outstanding unvested stock options | $ 251,700 | ||||
Stock-based compensation cost expected to be recognized over weighted-average period | 5 years 7 months 6 days | ||||
Unvested Stock Options | |||||
Class of Stock [Line Items] | |||||
Stock-based compensation cost expected to be recognized over weighted-average period | 2 years 6 months | ||||
Performance Units (PSUs) | |||||
Class of Stock [Line Items] | |||||
Shares available for issuance (in shares) | 320,000 | 112,000 | |||
Vested (in shares) | 33,000 | ||||
Intrinsic value of options exercised | $ 39,000 | $ 20,600 | $ 23,800 | ||
Expected to vest unrecognized stock-based compensation cost related to outstanding unvested stock options | $ 10,000 | ||||
Stock-based compensation cost expected to be recognized over weighted-average period | 1 year 9 months 18 days | ||||
Performance Units (PSUs) | Subsequent Event | |||||
Class of Stock [Line Items] | |||||
Vested (in shares) | 129,991 | ||||
Performance Units (PSUs) | Minimum | |||||
Class of Stock [Line Items] | |||||
Vesting percentage | 0.00% | ||||
Performance Units (PSUs) | Maximum | |||||
Class of Stock [Line Items] | |||||
Vesting percentage | 200.00% | ||||
Performance Units (PSUs) | Share-based Payment Arrangement, Tranche One | |||||
Class of Stock [Line Items] | |||||
Vesting period | 1 year | ||||
Performance Units (PSUs) | Share-based Payment Arrangement, Tranche Two | |||||
Class of Stock [Line Items] | |||||
Vesting period | 2 years | ||||
Performance Units (PSUs) | Share-based Payment Arrangement, Tranche Three | |||||
Class of Stock [Line Items] | |||||
Vesting period | 3 years | ||||
ESPP shares | |||||
Class of Stock [Line Items] | |||||
Shares reserved for issuance under plan (in shares) | 1,000,000 | ||||
Additional shares available for issuance under the plan (in shares) | 500,000 | ||||
Percentage of common stock shares increased under the plan | 1.00% | ||||
Common stock purchased under Employee Stock Purchase Plan (in shares) | 200,000 | 300,000 | 300,000 | ||
Stock-based compensation expense | $ 4,200 | $ 5,500 | $ 5,300 | ||
Shares available for issuance (in shares) | 2,987,542 | ||||
Purchase period | 6 months | ||||
2008 Equity Incentive Plan | |||||
Class of Stock [Line Items] | |||||
Shares available for issuance (in shares) | 0 | ||||
2014 Equity Incentive Plan | |||||
Class of Stock [Line Items] | |||||
Shares reserved for issuance under plan (in shares) | 5,000,000 | ||||
Shares available for issuance (in shares) | 13,904,194 | ||||
Shares available for grant under plan (in shares) | 5,184,878 | ||||
Percentage of shares of company's common stock outstanding for increase in shares reserved for issuance under stock plan | 5.00% |
Common Stock and Stockholders_5
Common Stock and Stockholders' Equity - Schedule of Stock Option, RSU and PSU Activities (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Number of Shares | |||
Beginning balance (in shares) | 2,718,000 | ||
Stock options granted (in shares) | 0 | ||
Stock options exercised (in shares) | (848,000) | ||
Stock options canceled/forfeited (in shares) | (207,000) | ||
Ending balance (in shares) | 1,663,000 | 2,718,000 | |
Options vested and expected to vest (in shares) | 1,662,000 | ||
Options vested and exercisable (in shares) | 1,310,000 | ||
Weighted- Average Exercise Price | |||
Beginning balance (in usd per share) | $ 50.55 | ||
Stock options granted (in usd per share) | 0 | ||
Stock options exercised (in usd per share) | 37.56 | ||
Stock options canceled/forfeited (in usd per share) | 70.77 | ||
Ending balance (in usd per share) | 54.66 | $ 50.55 | |
Options vested and expected to vest (in usd per share) | 54.65 | ||
Options vested and exercisable (in usd per share) | $ 50.66 | ||
Weighted-Average Remaining Contractual Term (in years) | |||
Balance | 5 years 7 months 6 days | 6 years 2 months 12 days | |
Options vested and expected to vest | 5 years 7 months 6 days | ||
Options vested and exercisable | 5 years | ||
Aggregate Intrinsic Value | |||
Beginning balance | $ 48,064 | ||
Stock options exercised | 39,003 | ||
Ending balance | 31,436 | $ 48,064 | |
Options vested and expected to vest | 31,436 | ||
Options vested and exercisable | $ 30,233 | ||
Restricted Stock Units (RSUs) | |||
Number of Shares | |||
Beginning balance (in shares) | 3,293,000 | ||
Granted (in shares) | 2,710,000 | ||
Vested (in shares) | (1,472,000) | ||
Canceled/forfeited (in shares) | (1,180,000) | ||
Ending balance (in shares) | 3,351,000 | 3,293,000 | |
Expected to vest (in shares) | 3,173,000 | ||
Weighted- Average Grant Date Fair Value | |||
Beginning balance (in usd per share) | $ 67.76 | ||
Granted (in usd per share) | 69.94 | ||
Vested (in usd per share) | 67.32 | ||
Canceled/forfeited (in usd per share) | 66.83 | ||
Ending balance (in usd per share) | 70.04 | $ 67.76 | |
Expected to vest (in usd per share) | $ 69.54 | ||
Weighted- Average Remaining Contractual Term (in years) | |||
Balance | 2 years 7 months 6 days | 2 years 9 months 18 days | |
Aggregate Intrinsic Value | |||
Beginning balance | $ 202,459 | ||
Ending balance | 224,096 | $ 202,459 | |
Expected to vest | $ 212,235 | ||
Performance Units (PSUs) | |||
Weighted-Average Remaining Contractual Term (in years) | |||
Options vested and expected to vest | 1 year 9 months 18 days | ||
Aggregate Intrinsic Value | |||
Stock options exercised | $ 39,000 | $ 20,600 | $ 23,800 |
Number of Shares | |||
Beginning balance (in shares) | 112,000 | ||
Granted (in shares) | 241,398 | ||
Vested (in shares) | (33,000) | ||
Canceled/forfeited (in shares) | 0 | ||
Ending balance (in shares) | 320,000 | 112,000 | |
Expected to vest (in shares) | 305,000 | ||
Weighted- Average Grant Date Fair Value | |||
Beginning balance (in usd per share) | $ 99.05 | ||
Granted (in usd per share) | 82.89 | ||
Vested (in usd per share) | 99.05 | ||
Ending balance (in usd per share) | 86.88 | $ 99.05 | |
Expected to vest (in usd per share) | $ 87 | ||
Weighted- Average Remaining Contractual Term (in years) | |||
Balance | 1 year 9 months 18 days | 2 years | |
Aggregate Intrinsic Value | |||
Beginning balance | $ 6,884 | ||
Ending balance | 21,430 | $ 6,884 | |
Expected to vest | $ 20,370 |
Common Stock and Stockholders_6
Common Stock and Stockholders' Equity - Schedule of Time-Based Restricted Stock Activity (Details) - Time-Based Restricted Stock - shares | Jun. 08, 2021 | Dec. 22, 2020 | Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of Shares of Time-Based Restricted Stock Granted as Consideration for Acquisitions (in shares) | 199,492 | 736,469 | 0 | ||
Pixie Labs Inc. | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 18 months | ||||
Pixie Labs Inc. | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 37 months | ||||
CodeStream Inc. | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 18 months | ||||
CodeStream Inc. | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 42 months |
Common Stock and Stockholders_7
Common Stock and Stockholders' Equity - Schedule of Assumptions Used to Estimate Fair Value of Stock Options Granted and ESPP Shares to be Issued (Detail) | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (years) | 6 months | 6 months | 6 months |
Dividend yield | 0.00% | 0.00% | 0.00% |
Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (years) | 0 years | 6 years | 6 years |
Dividend yield | 0.00% | 0.00% | 0.00% |
Minimum | ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected volatility | 38.00% | 55.00% | 33.00% |
Risk-free interest rate | 0.05% | 0.06% | 1.56% |
Minimum | Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected volatility | 0.00% | 44.00% | 41.00% |
Risk-free interest rate | 0.00% | 0.34% | 1.45% |
Maximum | ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected volatility | 76.00% | 76.00% | 60.00% |
Risk-free interest rate | 0.72% | 0.12% | 1.86% |
Maximum | Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected volatility | 0.00% | 46.00% | 42.00% |
Risk-free interest rate | 0.00% | 0.76% | 3.06% |
Common Stock and Stockholders_8
Common Stock and Stockholders' Equity - Schedule of Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Stock-based compensation expense | $ 153,039,000 | $ 135,143,000 | $ 99,536,000 | |||
Employee terminations and other costs | $ 0 | $ 12,600,000 | $ 0 | 12,612,000 | 0 | |
Stock-based compensation | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Employee terminations and other costs | 493,000 | |||||
Executive Officer | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Acceleration of share-based payment expense | 9,600,000 | |||||
Cost of revenue | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Stock-based compensation expense | 5,042,000 | 5,939,000 | 5,303,000 | |||
Research and development | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Stock-based compensation expense | 48,355,000 | 40,964,000 | 31,703,000 | |||
Sales and marketing | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Stock-based compensation expense | 48,986,000 | 54,695,000 | 43,548,000 | |||
Employee terminations and other costs | 11,329,000 | |||||
Sales and marketing | Stock-based compensation | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Employee terminations and other costs | 406,000 | |||||
General and administrative | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Stock-based compensation expense | 50,656,000 | $ 33,545,000 | $ 18,982,000 | |||
Employee terminations and other costs | 1,283,000 | |||||
General and administrative | Stock-based compensation | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||||
Employee terminations and other costs | $ 87,000 |
Income Taxes - Components of (L
Income Taxes - Components of (Loss) Income Before Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ (238,068) | $ (193,262) | $ (93,687) |
Foreign | 6,286 | 2,931 | 2,919 |
Loss before income taxes | $ (231,782) | $ (190,331) | $ (90,768) |
Income Taxes - Components of Pr
Income Taxes - Components of Provision for Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Current Provision: | |||
Federal | $ 0 | $ 0 | $ (1,177) |
State | 276 | (9) | 34 |
Foreign | 1,385 | 685 | 1,632 |
Total current provision | 1,661 | 676 | 489 |
Deferred Provision: | |||
Federal | (1,120) | 35 | 0 |
State | (64) | (96) | 0 |
Foreign | (154) | (56) | (278) |
Total deferred provision | (1,338) | (117) | (278) |
Total income tax provision | $ 323 | $ 559 | $ 211 |
Income Taxes - Schedule of Effe
Income Taxes - Schedule of Effective Federal Statutory Rate and Provision for Income Taxes (Detail) | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Federal statutory rate | 21.00% | 21.00% | 21.00% |
Effect of: | |||
State taxes, net of federal benefits | 3.50% | 3.00% | 3.00% |
Stock-based compensation | 3.80% | (1.50%) | (0.40%) |
Research and development credits, net of ASC 740-10 | 2.50% | 2.40% | 5.10% |
Permanent items | (4.40%) | (2.40%) | (4.00%) |
Foreign taxes | 0.00% | 0.20% | 0.40% |
Intraperiod allocation | 0.00% | 0.00% | 1.50% |
Other | 0.50% | 0.70% | 0.70% |
Valuation allowance | (27.00%) | (23.70%) | (27.50%) |
Effective tax rate | (0.10%) | (0.30%) | (0.20%) |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands | Mar. 31, 2022 | Mar. 31, 2021 |
Deferred tax assets: | ||
Accrued expenses | $ 2,568 | $ 3,429 |
Depreciation and amortization | 5,657 | 3,518 |
Capitalized research and development | 24,050 | 0 |
Net operating loss and other attribute carryforwards | 196,159 | 178,535 |
Stock based compensation | 20,695 | 14,987 |
Research and development credits | 31,695 | 25,932 |
Lease liability | 13,349 | 15,208 |
Convertible debt | 3,638 | 0 |
Other | 4,530 | 378 |
Gross deferred tax assets | 302,341 | 241,987 |
Valuation allowance | (276,475) | (198,794) |
Total deferred tax assets | 25,866 | 43,193 |
Deferred tax liabilities: | ||
Prepaids | (4,268) | (3,949) |
Intangibles | (2,679) | (1,923) |
Capitalized research and development | 0 | (4,405) |
Deferred contract acquisition costs | (7,326) | (15,520) |
Convertible debt | 0 | (3,991) |
Right of use asset | (10,809) | (12,748) |
Total deferred tax liabilities | (25,082) | (42,536) |
Total net deferred tax assets/(liabilities) | $ 784 | $ 657 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | 12 Months Ended | |||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Income Tax Contingency [Line Items] | ||||
Valuation allowance for company | $ 77,700,000 | $ 47,500,000 | ||
U.S. Federal net operating losses | 776,700,000 | |||
State net operating losses | 449,300,000 | |||
U.S. Federal net operating losses, amount limited to 80% of taxable income, carried forward indefinitely | $ 355,200,000 | |||
U.S. Federal net operating losses, taxable income threshold | 80.00% | |||
U.S. Federal net operating losses, amount subject to expiration in 2028 | $ 421,500,000 | |||
Minimum percentage of ownership required to increase in stock of the ownership | 5.00% | |||
Increase in ownership percentage of certain stockholders | 5000.00% | |||
Unrecognized tax benefits | $ 14,988,000 | 12,159,000 | $ 10,338,000 | $ 7,997,000 |
Unrecognized tax benefits that would affect income tax expense | 14,800,000 | |||
Accrued interest and penalties related to uncertain tax positions | 0 | $ 0 | $ 0 | |
U.S. | Research and Development | ||||
Income Tax Contingency [Line Items] | ||||
Research and development credits | 37,400,000 | |||
California | Research and Development | ||||
Income Tax Contingency [Line Items] | ||||
Research and development credits | 6,100,000 | |||
Oregon | Research and Development | ||||
Income Tax Contingency [Line Items] | ||||
Research and development credits | $ 1,000,000 |
Income Taxes - Schedule of Unre
Income Taxes - Schedule of Unrecognized Tax Benefits Reconciliation (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Unrecognized tax benefits, beginning balance | $ 12,159 | $ 10,338 | $ 7,997 |
Additions based on tax positions taken during the current period | 2,920 | 2,667 | 2,183 |
Additions based on tax positions taken during the prior period | 430 | 703 | 687 |
Reductions based on tax positions taken during the prior period | (521) | (1,549) | (529) |
Unrecognized tax benefits, ending balance | $ 14,988 | $ 12,159 | $ 10,338 |
Net Loss Per Share - Additional
Net Loss Per Share - Additional Information (Details) - shares shares in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 5,379 | 6,171 | 6,019 |
Convertible Debt Securities | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 4,500 |
Net Loss Per Share - Computatio
Net Loss Per Share - Computation of Net Loss Per Share Attributable to Common Stockholders, Basic and Diluted (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Numerator: | |||
Net loss attributable to New Relic | $ (250,402) | $ (192,610) | $ (88,937) |
Denominator: | |||
Weighted-average shares used to compute net loss per share, basic (in shares) | 64,592 | 61,070 | 58,601 |
Weighted-average shares used to compute net loss per share, diluted (in shares) | 64,592 | 61,070 | 58,601 |
Net loss attributable to New Relic per share, basic (in usd per share) | $ (3.88) | $ (3.15) | $ (1.52) |
Net loss attributable to New Relic per share, diluted (in usd per share) | $ (3.88) | $ (3.15) | $ (1.52) |
Net Loss Per Share - Antidiluti
Net Loss Per Share - Antidilutive Securities Excluded from Computation of Diluted Net Loss per Common Share of Common Stock Equivalents (Detail) - shares shares in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 5,379 | 6,171 | 6,019 |
ESPP shares | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 45 | 48 | 69 |
Restricted Stock Units (RSUs) | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 3,351 | 3,293 | 3,100 |
Performance Units (PSUs) | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 320 | 112 | |
Options to purchase common stock | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted net loss per common share (in shares) | 1,663 | 2,718 | 2,850 |
Employee Benefit Plan - Additio
Employee Benefit Plan - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Postemployment Benefits [Abstract] | |||
Contributions to employee benefit plan | $ 8.5 | $ 8.3 | $ 7.7 |
Revenue by Geographic Locatio_2
Revenue by Geographic Location - Schedule of Revenue by Geographic Areas (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Segment Reporting Information [Line Items] | |||
Total revenue | $ 785,521 | $ 667,648 | $ 599,510 |
United States | |||
Segment Reporting Information [Line Items] | |||
Total revenue | 528,922 | 460,944 | 417,827 |
EMEA | |||
Segment Reporting Information [Line Items] | |||
Total revenue | 121,301 | 104,184 | 98,651 |
APAC | |||
Segment Reporting Information [Line Items] | |||
Total revenue | 79,940 | 62,590 | 50,831 |
Other | |||
Segment Reporting Information [Line Items] | |||
Total revenue | $ 55,358 | $ 39,930 | $ 32,201 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2020 | |
Related Party Transactions [Abstract] | |||
Revenue from sales to related parties | $ 3.1 | $ 1.7 | $ 1 |
Expenses related to purchases from related parties | $ 0 | $ 0 | $ 1.4 |
Restructuring (Details)
Restructuring (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Restructuring and Related Activities [Abstract] | |||||
Employee terminations and other costs | $ 0 | $ 12,600,000 | $ 0 | $ 12,612,000 | $ 0 |
Restructuring - Schedule of Res
Restructuring - Schedule of Restructuring Charges (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | $ 0 | $ 12,600,000 | $ 0 | $ 12,612,000 | $ 0 |
Sales and marketing | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 11,329,000 | ||||
General and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 1,283,000 | ||||
Severance and other employee costs | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 11,989,000 | ||||
Severance and other employee costs | Sales and marketing | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 10,819,000 | ||||
Severance and other employee costs | General and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 1,170,000 | ||||
Stock-based compensation | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 493,000 | ||||
Stock-based compensation | Sales and marketing | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 406,000 | ||||
Stock-based compensation | General and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 87,000 | ||||
Asset impairment | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 130,000 | ||||
Asset impairment | Sales and marketing | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | 104,000 | ||||
Asset impairment | General and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Employee terminations and other costs | $ 26,000 |